{"meta":{"query_hash":"7bde6250bcbc","filters":{"venue":"eJHaem"},"cohort_total":83,"direct_labels_cover":0,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7bde6250bcbc","api":"https://metacan.xera.ac/api/v1/cohort?venue=eJHaem"},"results":[{"id":"W3014488763","doi":"10.1002/jha2.4","title":"Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"","keywords":"Bortezomib; Medicine; Internal medicine; Dexamethasone; Clinical endpoint; Multiple myeloma; Placebo; Hazard ratio; Interim analysis; Adverse effect; Surgery; Gastroenterology; Oncology; Randomized controlled trial; Confidence interval; Pathology","score_opus":0.017713981571373643,"score_gpt":0.27255795567471003,"score_spread":0.25484397410333637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014488763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860534,0.0003790717,0.00004580975,0.00019400194,0.000011990917,0.012925601,0.000039708044,0.00009056958,0.00025984985],"genre_scores_gemma":[0.9976381,0.000052619103,0.00089140417,0.000085150554,0.000032690943,0.0008258062,0.00017988784,0.000100227786,0.00019411066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99625915,0.0005633219,0.00079402793,0.0008215549,0.0009469695,0.0006149574],"domain_scores_gemma":[0.9972893,0.0007026774,0.00042944765,0.00056149147,0.00036609996,0.00065100857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004710201,0.0005939218,0.0025567403,0.00028269397,0.000109617235,0.00003691051,0.00014435915,0.00011533118,0.00007378933],"category_scores_gemma":[0.0006506631,0.00033456858,0.00010161416,0.00062734616,0.00036368478,0.00022234212,0.00006659671,0.0004640046,0.000005910652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5690397,0.005644873,0.41952178,0.00009954561,0.0013802486,0.0005294092,0.0018569716,0.000010818934,0.000057008878,0.0000017502368,0.000023878936,0.0018340086],"study_design_scores_gemma":[0.7714443,0.03996286,0.18437351,0.00028699395,0.00087223254,0.00001604902,0.0009487294,0.0015590618,0.00022943421,5.216477e-7,0.00002409271,0.00028218888],"about_ca_topic_score_codex":0.00062134425,"about_ca_topic_score_gemma":0.00061802333,"teacher_disagreement_score":0.23514827,"about_ca_system_score_codex":0.00012111572,"about_ca_system_score_gemma":0.00021718728,"threshold_uncertainty_score":0.99991065},"labels":[],"label_agreement":null},{"id":"W3037186634","doi":"10.1002/jha2.49","title":"Therapy related acute myeloid leukemia with blast cannibalism and cytophagocytosis","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"","keywords":"Medicine; Myeloid leukemia; Bone marrow; Context (archaeology); Leukemia; Internal medicine; Neutropenia; Oncology; Pathology; Chemotherapy; Biology","score_opus":0.018915648027950753,"score_gpt":0.24049779070889174,"score_spread":0.22158214268094098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037186634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898101,0.00050898583,0.00005568903,0.005687186,0.00010981342,0.00021726443,0.000008834666,0.00015126544,0.0034508426],"genre_scores_gemma":[0.9864216,0.00079690234,0.00034968145,0.010222881,0.0002251802,0.000012920269,0.00003977343,0.000030165373,0.001900906],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923444,0.00003329318,0.00014515588,0.000286543,0.00012055931,0.00018000632],"domain_scores_gemma":[0.9994974,0.000026030228,0.00005202935,0.0001551551,0.000048868613,0.00022049509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003541399,0.00015176146,0.00028710108,0.0000357102,0.00007192612,0.000009998313,0.000043151133,0.000109011606,0.00039420216],"category_scores_gemma":[0.000014028293,0.00010698455,0.000044001445,0.00020690572,0.00010728858,0.000050484578,0.000022622895,0.000241637,0.00010853969],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012342893,0.00017865105,0.021838108,0.00019182097,0.0019789808,0.002227352,0.018085519,0.000064167245,0.8430912,0.0009582855,0.053936016,0.045107033],"study_design_scores_gemma":[0.041807637,0.018382706,0.34171557,0.00031220703,0.000930912,0.0033217466,0.0025562735,0.0027317666,0.1689896,0.00024360121,0.41737694,0.0016310387],"about_ca_topic_score_codex":0.000042238924,"about_ca_topic_score_gemma":0.0000062294885,"teacher_disagreement_score":0.6741016,"about_ca_system_score_codex":0.000043671138,"about_ca_system_score_gemma":0.00012028831,"threshold_uncertainty_score":0.43627033},"labels":[],"label_agreement":null},{"id":"W3040698717","doi":"10.1002/jha2.13","title":"Anaplastic large cell lymphoma as a posttransplant lymphoproliferative disorder in a renal transplant patient: A case report","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Vincristine; Lymphoma; Anaplastic large-cell lymphoma; Etoposide; Lymph node biopsy; Post-transplant lymphoproliferative disorder; Cyclophosphamide; Prednisone; Lymph node; Biopsy; Chemotherapy; Pathology; Transplantation; Internal medicine; Rituximab","score_opus":0.009391484411419019,"score_gpt":0.2372574317403498,"score_spread":0.22786594732893078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040698717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112445,0.0008479302,0.0003158909,0.0019509676,0.00009594265,0.00061799155,0.00023790257,0.00009292332,0.004715979],"genre_scores_gemma":[0.9960418,0.000117345364,0.00007209555,0.0032120843,0.000066974055,0.000070125745,0.00021711104,0.000042765474,0.00015973771],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979956,0.000068062385,0.0005176996,0.00052158657,0.00036218096,0.0005348752],"domain_scores_gemma":[0.99920666,0.000046671008,0.00013468135,0.00019890339,0.000060672504,0.00035239005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010639438,0.00028885785,0.00048410305,0.000106433465,0.00011249457,0.000022073727,0.00006874283,0.00015830026,0.00021738371],"category_scores_gemma":[0.00007207536,0.00025353,0.00016407181,0.00046101736,0.000043933767,0.00009519986,0.000018533001,0.00019199752,0.00006958848],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007198284,0.0024488354,0.035814337,0.0003387123,0.0002319459,0.89714384,0.050301343,0.00016059444,0.0013481729,0.00017483691,0.0015960853,0.0032430177],"study_design_scores_gemma":[0.33346954,0.029988239,0.023505185,0.00310525,0.0031067955,0.4114765,0.045399234,0.038030762,0.026907075,0.00061794533,0.0785372,0.005856269],"about_ca_topic_score_codex":0.0010431713,"about_ca_topic_score_gemma":0.001236481,"teacher_disagreement_score":0.48566735,"about_ca_system_score_codex":0.00016789285,"about_ca_system_score_gemma":0.00042081682,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W3042164741","doi":"10.1002/jha2.62","title":"Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovative Targeting Solutions (Canada); Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Simon Fraser University; Princess Margaret Cancer Centre; Terry Fox Research Institute; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control","funders":"Terry Fox Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Socioeconomic status; Quality of life (healthcare); Proportional hazards model; Myeloid leukemia; Internal medicine; Myelodysplastic syndromes; Demography; Gerontology; Oncology; Environmental health; Population; Bone marrow","score_opus":0.03267171272506571,"score_gpt":0.27893597066259895,"score_spread":0.24626425793753326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042164741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965168,0.00012112205,0.000004768814,0.0021062961,0.000019868761,0.0002178653,0.000055902932,0.000010114336,0.0009472596],"genre_scores_gemma":[0.99929285,0.000029401886,0.00005925584,0.0004918249,0.000029857318,0.00000466477,0.00002513806,0.00001853215,0.00004845317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986087,0.00014241235,0.00045729437,0.00021754614,0.00034229894,0.00023171782],"domain_scores_gemma":[0.9989201,0.00034738862,0.00023435999,0.00015861655,0.000068944355,0.00027061274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048434213,0.00011445578,0.0006383753,0.00008506697,0.000016903043,0.000002670856,0.00011480494,0.00007749611,0.0001080134],"category_scores_gemma":[0.0008052032,0.00009943708,0.000028940138,0.00029780497,0.00015962319,0.00003950963,0.00007335763,0.00033621865,0.000002426635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041377783,0.000025841688,0.99545777,0.00015407549,0.00014670755,0.000022319886,0.0009101842,0.000015346166,0.0011413763,0.00007143872,0.0010032076,0.00063793623],"study_design_scores_gemma":[0.0035734996,0.00016672105,0.99147326,0.000036577905,0.000015253401,0.0000011425584,0.0020995103,0.00024332954,0.0021458126,0.000006897133,0.00013395365,0.00010404436],"about_ca_topic_score_codex":0.49951544,"about_ca_topic_score_gemma":0.5447936,"teacher_disagreement_score":0.04527814,"about_ca_system_score_codex":0.0011325988,"about_ca_system_score_gemma":0.007821427,"threshold_uncertainty_score":0.99780333},"labels":[],"label_agreement":null},{"id":"W3042591581","doi":"10.1002/jha2.57","title":"Etoposide‐based treatment of adult HLH is associated with high biochemical response but poor survival outcomes","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Etoposide; Medicine; Ferritin; Retrospective cohort study; Internal medicine; Serum ferritin; Pediatrics; Gastroenterology; Chemotherapy","score_opus":0.03433233213210762,"score_gpt":0.30106926869226713,"score_spread":0.2667369365601595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042591581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778384,0.00012639393,0.000024101233,0.021091087,0.000028316294,0.00037740666,0.00006488217,0.00007913092,0.00037029915],"genre_scores_gemma":[0.9963602,0.000019280318,0.00012712905,0.0014816208,0.000028261784,0.000025981026,0.000079367615,0.000032931224,0.0018452466],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984552,0.00014110579,0.00033876632,0.0002707765,0.0005071817,0.00028691356],"domain_scores_gemma":[0.9989267,0.0002747519,0.00011027728,0.00028038718,0.00022633272,0.00018154441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012881025,0.00019702326,0.000656771,0.00007187824,0.000050325452,0.000009661751,0.00010200673,0.00012346159,0.00044397154],"category_scores_gemma":[0.0006676753,0.00013472515,0.0001560656,0.00026828292,0.00014393103,0.000037344704,0.000026859158,0.00013615936,0.0000664744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04309817,0.0032377043,0.58866876,0.0002871057,0.002329602,0.0012687927,0.005576445,0.000014403453,0.33627382,0.00019814195,0.015720626,0.0033263979],"study_design_scores_gemma":[0.016186347,0.006101259,0.32170537,0.00014265615,0.00023196817,0.0000053053163,0.0010098835,0.00059955806,0.6500555,0.000009843987,0.0036389204,0.00031337986],"about_ca_topic_score_codex":0.00021688036,"about_ca_topic_score_gemma":0.000008833198,"teacher_disagreement_score":0.3137817,"about_ca_system_score_codex":0.00011768973,"about_ca_system_score_gemma":0.00041732364,"threshold_uncertainty_score":0.54939324},"labels":[],"label_agreement":null},{"id":"W3043987559","doi":"10.1002/jha2.67","title":"Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect<sup>®</sup> CLL Registry","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Chemoimmunotherapy; Medicine; Chronic lymphocytic leukemia; Quality of life (healthcare); Rituximab; Internal medicine; Observational study; Leukemia; Pediatrics; Physical therapy; Lymphoma","score_opus":0.05282141469533935,"score_gpt":0.3005933488246032,"score_spread":0.24777193412926385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043987559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056214,0.0019275704,0.000027757455,0.0050692395,0.00004670125,0.0014234281,0.0003795248,0.00012488669,0.00043877886],"genre_scores_gemma":[0.9973415,0.0002110728,0.0000766076,0.00086422294,0.0002575496,0.000038565217,0.0009177685,0.000068913476,0.00022380636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949064,0.00043777676,0.0017859825,0.00093279476,0.0011352596,0.0008017763],"domain_scores_gemma":[0.9956749,0.0015411115,0.0006705446,0.0012229995,0.00028736022,0.0006030514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087874033,0.00041692707,0.0012741862,0.00009394352,0.00014714459,0.00002752584,0.0004887938,0.0002971692,0.00018756911],"category_scores_gemma":[0.0032970454,0.00028135764,0.00016595007,0.0011614397,0.0004729612,0.00011596446,0.00021327034,0.00077188184,0.0001058594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.121295266,0.0016828574,0.6381113,0.0052195215,0.0033874237,0.001954513,0.037141785,0.1286016,0.00016638785,0.00034824063,0.054849803,0.0072413236],"study_design_scores_gemma":[0.35551384,0.0056135994,0.37113968,0.002673363,0.00025795985,0.000060000995,0.0011919828,0.25962293,0.00068890606,0.00007319314,0.0022279338,0.0009366186],"about_ca_topic_score_codex":0.08709266,"about_ca_topic_score_gemma":0.0034542256,"teacher_disagreement_score":0.26697162,"about_ca_system_score_codex":0.046722814,"about_ca_system_score_gemma":0.037220843,"threshold_uncertainty_score":0.9999639},"labels":[],"label_agreement":null},{"id":"W3080496620","doi":"10.1002/jha2.77","title":"Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Pharmaceuticals","keywords":"Bortezomib; Multiple myeloma; Dosing; Thalidomide; Medicine; Dexamethasone; Matching (statistics); Internal medicine; Oncology; Pathology","score_opus":0.040852141848497864,"score_gpt":0.29436453962409775,"score_spread":0.25351239777559986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080496620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699545,0.00075625465,0.00022579177,0.00018614241,0.000010769641,0.0015302534,0.0001667444,0.000041347368,0.00008727366],"genre_scores_gemma":[0.99411094,0.000113803704,0.0054454235,0.000050055784,0.0000150480855,0.000028622982,0.00018294602,0.000045702487,0.0000074354434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781865,0.00016394941,0.0005427689,0.00048689032,0.00058978086,0.00039797643],"domain_scores_gemma":[0.99839866,0.00053280435,0.0002844856,0.00025604473,0.0001533037,0.0003746767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015231103,0.00033688525,0.0013033762,0.00019626119,0.000089612164,0.000024913927,0.00010488702,0.000108652544,0.000014728254],"category_scores_gemma":[0.00013111118,0.00024074492,0.000040903975,0.0003664471,0.0002308909,0.00013144682,0.000053270356,0.00031198288,0.0000018769408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035039935,0.0012459725,0.94949776,0.0005838032,0.00045512937,0.0001093244,0.0069734524,0.00033288114,0.0015597538,0.000015510936,0.000007351526,0.0041791084],"study_design_scores_gemma":[0.06487334,0.0016793283,0.9126522,0.0016098738,0.00019736023,0.00000746903,0.0012858075,0.0040640645,0.013398078,0.0000048682214,0.0000066825187,0.00022091188],"about_ca_topic_score_codex":0.0011032711,"about_ca_topic_score_gemma":0.0007680902,"teacher_disagreement_score":0.036845557,"about_ca_system_score_codex":0.00005045355,"about_ca_system_score_gemma":0.000102594844,"threshold_uncertainty_score":0.98172927},"labels":[],"label_agreement":null},{"id":"W3095036810","doi":"10.1002/jha2.125","title":"T‐lymphoblastic transformation of chronic myeloid leukemia","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Population; Pathology; Medicine; Myeloid; Bone marrow; Complete blood count; Immunology; Gastroenterology; Molecular biology; Biology","score_opus":0.018718451764002088,"score_gpt":0.2517856187239334,"score_spread":0.23306716695993132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095036810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98060477,0.0009406101,0.0022622962,0.0016931515,0.0001548589,0.0005713324,0.000019909612,0.00015494128,0.013598162],"genre_scores_gemma":[0.9985386,0.00011311745,0.00033332861,0.00038111804,0.0002995152,0.00001597384,0.000060052957,0.000025391844,0.00023288475],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989393,0.000019536637,0.00033531233,0.00020030398,0.00028352946,0.00022206706],"domain_scores_gemma":[0.9994294,0.000041195475,0.000086533626,0.00020837635,0.000049040667,0.00018543917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005346846,0.00015291278,0.00032376844,0.000050755883,0.000031294443,0.0000052407454,0.00008629055,0.00008311623,0.0006338691],"category_scores_gemma":[0.000059545848,0.00013439075,0.000118802294,0.00023732903,0.00005933686,0.000101560654,0.00001965531,0.00012989771,0.0003638079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028559922,0.0008277266,0.0058877417,0.007282769,0.0015988345,0.00055608904,0.03162439,0.0032622912,0.4517879,0.0050792303,0.01641339,0.47282365],"study_design_scores_gemma":[0.043563258,0.006912859,0.03276623,0.001135322,0.0013346423,0.00047541904,0.0010605152,0.097305045,0.7192554,0.00019604417,0.095031634,0.00096362503],"about_ca_topic_score_codex":0.000048731752,"about_ca_topic_score_gemma":0.00000844328,"teacher_disagreement_score":0.47186002,"about_ca_system_score_codex":0.0015406341,"about_ca_system_score_gemma":0.00095882604,"threshold_uncertainty_score":0.69404215},"labels":[],"label_agreement":null},{"id":"W3104212033","doi":"10.1002/jha2.122","title":"Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SAIT Polytechnic; Alberta Cancer Foundation; Vancouver General Hospital; CancerCare Manitoba; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Neutropenia; Tolerability; Refractory (planetary science); Regimen; Gastroenterology; Adverse effect; Cohort; Oncology; Multiple myeloma; Surgery; Bortezomib; Toxicity","score_opus":0.03176295292882655,"score_gpt":0.27793286999841593,"score_spread":0.24616991706958938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104212033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974278,0.00020659689,0.00004063042,0.0007837382,0.000027783586,0.00076451903,0.000026106023,0.00006481279,0.0006580172],"genre_scores_gemma":[0.9948357,0.000032301592,0.0041321404,0.00042695712,0.00006718282,0.000034211083,0.00010706311,0.000036347003,0.00032810454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985608,0.00007026875,0.00022250589,0.00039950496,0.00039924847,0.0003477153],"domain_scores_gemma":[0.999003,0.0001749803,0.000056529014,0.0002345214,0.000089929614,0.00044105193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089694346,0.00019397725,0.0003514251,0.000093760835,0.0000637362,0.000019065015,0.00006897475,0.00008440672,0.00014322164],"category_scores_gemma":[0.0006826576,0.00012464754,0.00003000164,0.0003253036,0.00008217935,0.00012428909,0.00006396156,0.00031336874,0.0000649078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010078714,0.00047910196,0.9552587,0.00008864624,0.00009735021,0.0005501188,0.0006854854,0.0000012092169,0.00026275023,0.000004114684,0.00059258274,0.031901196],"study_design_scores_gemma":[0.024643658,0.0029089195,0.966438,0.00011274326,0.000033590433,0.00000865757,0.00013090647,0.0009950679,0.0005438475,0.0000033225122,0.0040234313,0.00015785373],"about_ca_topic_score_codex":0.00007123077,"about_ca_topic_score_gemma":0.00013236071,"teacher_disagreement_score":0.03174334,"about_ca_system_score_codex":0.00007628464,"about_ca_system_score_gemma":0.00010286626,"threshold_uncertainty_score":0.508298},"labels":[],"label_agreement":null},{"id":"W3110658142","doi":"10.1002/jha2.151","title":"Primary mediastinal large B‐cell lymphoma","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Rituximab; Atelectasis; Lymphoma; Pleural effusion; Radiology; Prednisone; Mediastinal Shift; Pericardial effusion; Lung; Cyclophosphamide; Surgery; Internal medicine; Chemotherapy","score_opus":0.01851631812072328,"score_gpt":0.23517462444860202,"score_spread":0.21665830632787875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110658142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291976,0.0015007835,0.00006979205,0.007910575,0.00015175868,0.00027136935,0.000021290169,0.00014922973,0.06072757],"genre_scores_gemma":[0.98831755,0.000075625634,0.00091263006,0.009606333,0.00045575283,0.000028160945,0.00006125042,0.000020295724,0.0005224069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908286,0.000016446731,0.00015685383,0.00024447753,0.0002493389,0.00025000868],"domain_scores_gemma":[0.99939895,0.000045739307,0.00004050298,0.0001669746,0.0000317949,0.00031602939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047124315,0.00013517996,0.00024743355,0.000023617056,0.000049800245,0.000012144044,0.00006254645,0.000051507548,0.00044154748],"category_scores_gemma":[0.000034633424,0.00010512417,0.000106404426,0.00012082911,0.000017236915,0.000040814655,0.000059200058,0.000041345207,0.0011349684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012159173,0.0117870625,0.46860996,0.00086650753,0.0004607525,0.008909652,0.0065290052,0.0000022377249,0.009863276,0.0020160386,0.31413692,0.17560266],"study_design_scores_gemma":[0.02209896,0.0010113353,0.58786684,0.000075490454,0.00027282996,0.00015423905,0.0002495455,0.000186138,0.02629915,0.00002874257,0.36148873,0.00026799826],"about_ca_topic_score_codex":0.000011856825,"about_ca_topic_score_gemma":0.0000016465193,"teacher_disagreement_score":0.17533466,"about_ca_system_score_codex":0.00010810303,"about_ca_system_score_gemma":0.00013839408,"threshold_uncertainty_score":0.9996428},"labels":[],"label_agreement":null},{"id":"W3136342625","doi":"10.1002/jha2.187","title":"DNA methylation analysis improves the prognostication of acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Institute on Aging; Terry Fox Research Institute; Genome British Columbia","keywords":"DNA methylation; Epigenomics; Myeloid leukemia; Methylation; Oncology; Gene; Computational biology; Medicine; Bioinformatics; Internal medicine; Biology; Genetics; Gene expression","score_opus":0.018759141319488224,"score_gpt":0.3098336599191932,"score_spread":0.29107451859970496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136342625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98570895,0.00047778236,0.0038231425,0.005050457,0.0000649808,0.00045705782,0.000020487516,0.000052476906,0.0043446575],"genre_scores_gemma":[0.99279886,0.0001860898,0.0028784939,0.00024181479,0.00014178241,0.000044048043,0.0002508444,0.000018431749,0.003439605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985557,0.0001285507,0.00032726637,0.00028621466,0.00047328358,0.00022896413],"domain_scores_gemma":[0.9983566,0.00027162026,0.00013124965,0.000657476,0.0004939039,0.00008917758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047417966,0.00011744904,0.00034462498,0.00018360077,0.00008409318,0.000023466575,0.00015063264,0.00009696694,0.00021544914],"category_scores_gemma":[0.00052048475,0.00007999252,0.00022081514,0.0017799754,0.00012830352,0.000089463436,0.00010099418,0.00026437402,0.000047979906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001824624,0.00010506776,0.010350461,0.00009930046,0.004881371,0.00008081254,0.001375454,0.000045063556,0.9179127,0.0015344131,0.0022146401,0.061218236],"study_design_scores_gemma":[0.0009571724,0.0001440709,0.3175728,0.000028007817,0.004683332,0.000045888948,0.00054858165,0.0094693955,0.6623795,0.00031737483,0.00371612,0.00013773332],"about_ca_topic_score_codex":0.000078285804,"about_ca_topic_score_gemma":0.000025551994,"teacher_disagreement_score":0.30722234,"about_ca_system_score_codex":0.0003122265,"about_ca_system_score_gemma":0.0007511891,"threshold_uncertainty_score":0.32620004},"labels":[],"label_agreement":null},{"id":"W3141847896","doi":"10.1002/jha2.194","title":"A case of multiple myeloma with plasma cell cannibalism and cytophagocytosis","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"","keywords":"Plasma cell; Pathology; Medicine; Bone marrow; Biopsy; Multiple myeloma; Plasma cell leukemia; Nuclear medicine; Internal medicine","score_opus":0.01657346320460847,"score_gpt":0.24704454494764697,"score_spread":0.2304710817430385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141847896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958265,0.00066162244,0.000017630286,0.00055603514,0.000039695027,0.0002660599,0.000055264,0.000021818709,0.002555371],"genre_scores_gemma":[0.9953113,0.00010225664,0.003243668,0.00019625036,0.000050195806,0.000057669156,0.000025861913,0.000020847414,0.0009919496],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991698,0.00003499162,0.00018212337,0.0002872645,0.00014807415,0.00017772923],"domain_scores_gemma":[0.9992254,0.00014914878,0.0000662212,0.00023828486,0.00015399615,0.00016699177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045396166,0.0001616638,0.00036106445,0.000048854374,0.00007104591,0.000013309662,0.000020929956,0.00005894009,0.00016259446],"category_scores_gemma":[0.000044238233,0.00011740746,0.000052001917,0.0001489959,0.00006992218,0.00003947392,0.000035869427,0.00008952794,0.000010063795],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011874152,0.0025900102,0.77386606,0.00086476246,0.000935892,0.14620739,0.009843573,0.000029548979,0.037128203,0.00081734447,0.003113579,0.023416212],"study_design_scores_gemma":[0.0070104976,0.00085309806,0.042149622,0.00015683101,0.00031919207,0.014980166,0.0013340529,0.00034392122,0.92980295,0.000011463657,0.0028504366,0.00018776239],"about_ca_topic_score_codex":0.00028261048,"about_ca_topic_score_gemma":0.00083026674,"teacher_disagreement_score":0.89267474,"about_ca_system_score_codex":0.00004715375,"about_ca_system_score_gemma":0.00016356149,"threshold_uncertainty_score":0.4787737},"labels":[],"label_agreement":null},{"id":"W3199114236","doi":"10.1002/jha2.292","title":"A practical and effective strategy in East Asia to prevent anti‐D alloimmunization in patients by C/c phenotyping of serologic RhD‐negative blood donors","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Blood Services","keywords":"Serology; Genotyping; Red blood cell; Rh blood group system; Medicine; Titer; Immunology; Red Cell; Antigen; Antibody; Virology; Genotype; Biology; Genetics; Internal medicine; Gene","score_opus":0.010504220983037016,"score_gpt":0.2667663454820549,"score_spread":0.2562621244990179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199114236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998118,0.00013262479,0.00016304111,0.00050983607,0.000025264726,0.0006924865,0.00000745055,0.0000084226795,0.00034291873],"genre_scores_gemma":[0.9991948,0.00005894899,0.0005755132,0.00007409064,0.000008521098,0.000020822614,0.00003879269,0.000010598771,0.00001788487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990743,0.00016009827,0.00023913414,0.00023916297,0.00013587013,0.0001514606],"domain_scores_gemma":[0.9995957,0.00008326725,0.000056291647,0.00011066695,0.0000934169,0.000060627655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016568226,0.00010601727,0.00028623108,0.000080923295,0.00002096408,0.0000080138025,0.000022752727,0.000087223154,0.00002014525],"category_scores_gemma":[0.00018684556,0.00009528218,0.00002396802,0.00035416964,0.000028698854,0.00009050501,0.00003944392,0.0001986379,0.0000016474415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069666805,0.0057541085,0.9436174,0.00030345708,0.0001429014,0.00010732703,0.004038042,0.00007805545,0.030554136,0.00053817715,0.000038962753,0.014130767],"study_design_scores_gemma":[0.0039377203,0.0008248531,0.9686344,0.00038974537,0.0000817079,0.00001123158,0.0006244229,0.00023022636,0.025038175,0.00012458015,0.000007692466,0.00009521436],"about_ca_topic_score_codex":0.0002180012,"about_ca_topic_score_gemma":0.00029231998,"teacher_disagreement_score":0.025017032,"about_ca_system_score_codex":0.00002830922,"about_ca_system_score_gemma":0.000057640613,"threshold_uncertainty_score":0.38854948},"labels":[],"label_agreement":null},{"id":"W3202459519","doi":"10.1002/jha2.309","title":"Hydroxycarbamide‐related cutaneous ulcer complicated by osteomyelitis","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hydroxycarbamide; Thrombocytosis; Osteomyelitis; Surgery; White blood cell; Amputation; Internal medicine; Dermatology; Chemotherapy; Platelet","score_opus":0.008171183667236324,"score_gpt":0.24949338338643917,"score_spread":0.24132219971920285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202459519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93089706,0.002546247,0.000026494052,0.012435095,0.00022819685,0.00050192984,0.000112530026,0.00022085692,0.053031582],"genre_scores_gemma":[0.98164535,0.00031757395,0.0003317223,0.0015140763,0.00012451147,0.000082892846,0.0007688972,0.00004601297,0.0151689565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842334,0.00007359176,0.0003514476,0.0004959267,0.00029927705,0.00035639634],"domain_scores_gemma":[0.99888,0.00013494796,0.00007267618,0.00044379194,0.0002073574,0.0002611987],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004922634,0.00024935446,0.00047108298,0.00004655632,0.00011655281,0.000035010064,0.000064404056,0.00014025066,0.0032946512],"category_scores_gemma":[0.00009432205,0.00021461089,0.00013286901,0.00033826954,0.00007161398,0.00004191626,0.000054874316,0.00022908348,0.0010336131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707034,0.0038409354,0.2141743,0.00036408647,0.0042542103,0.034670845,0.0029972873,0.000090641945,0.13862382,0.008613202,0.42515615,0.16664383],"study_design_scores_gemma":[0.007560274,0.0010279596,0.043369476,0.0003871557,0.00067003985,0.01010729,0.00031546087,0.00073110324,0.35684016,0.0006850003,0.5775213,0.0007847658],"about_ca_topic_score_codex":0.000080060905,"about_ca_topic_score_gemma":0.000027793796,"teacher_disagreement_score":0.21821636,"about_ca_system_score_codex":0.00014992351,"about_ca_system_score_gemma":0.00013009377,"threshold_uncertainty_score":0.9997442},"labels":[],"label_agreement":null},{"id":"W3203750859","doi":"10.1002/jha2.304","title":"Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Antibody; Immune system; Recombinant DNA; Phagocytosis; Immunology; Immune thrombocytopenia; Receptor; Monocyte; In vitro; Platelet; Fc receptor; Cell; Medicine; Chemistry; Internal medicine; Biochemistry","score_opus":0.04369662644633043,"score_gpt":0.33555583396035227,"score_spread":0.29185920751402183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203750859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418956,0.00024026271,0.00012873366,0.0026082883,0.0002283166,0.0006277662,0.000072642055,0.000031194322,0.0018732072],"genre_scores_gemma":[0.9880069,0.00008975873,0.0035131217,0.00049383676,0.00007622739,0.000019990623,0.00010588748,0.000034680867,0.0076595973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780405,0.00014233799,0.00062495284,0.00038218955,0.0006228747,0.00042361522],"domain_scores_gemma":[0.99815017,0.00018039197,0.00011943486,0.00065367727,0.0005033993,0.00039295582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039549335,0.00021828253,0.0010221077,0.00019582777,0.00007027864,0.000014655296,0.0002711327,0.000081639024,0.0008253567],"category_scores_gemma":[0.00034452757,0.00018226467,0.0002118218,0.00071097515,0.000070948605,0.00004218722,0.00037461732,0.00022678958,0.00036902016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024066253,0.0008299231,0.0011013559,0.00024745302,0.00019345418,0.0002374053,0.0010489769,0.0000144596,0.9854098,0.002023923,0.0043640756,0.002122545],"study_design_scores_gemma":[0.0023624836,0.0010748437,0.04376151,0.0003946502,0.00006621093,0.000047374135,0.0003286721,0.000102736885,0.94382864,0.00017947264,0.0076393913,0.00021403462],"about_ca_topic_score_codex":0.0015567909,"about_ca_topic_score_gemma":0.00014874265,"teacher_disagreement_score":0.042660154,"about_ca_system_score_codex":0.000057586967,"about_ca_system_score_gemma":0.0002794779,"threshold_uncertainty_score":0.9037077},"labels":[],"label_agreement":null},{"id":"W4200379562","doi":"10.1002/jha2.286","title":"Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; North York General Hospital; University Health Network","funders":"","keywords":"Medicine; Vincristine; Cytokine release syndrome; Rituximab; Internal medicine; Lymphoma; Oncology; Gastroenterology; Cyclophosphamide; Surgery; Chimeric antigen receptor; Chemotherapy; Immunotherapy; Cancer","score_opus":0.01654318805029646,"score_gpt":0.2790110379962011,"score_spread":0.2624678499459046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200379562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821212,0.004237295,0.00019271216,0.0009277096,0.00043386692,0.0011055989,0.00022790219,0.00021855632,0.010535105],"genre_scores_gemma":[0.9067006,0.0016705109,0.0009079716,0.0009958465,0.00048139252,0.00020950199,0.0002379702,0.00013235696,0.08866385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997641,0.00015045448,0.00033055927,0.0006017949,0.0005050522,0.0007710826],"domain_scores_gemma":[0.998433,0.00016344481,0.000051973017,0.0007286913,0.0003298849,0.00029302516],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003063721,0.00028877833,0.000528847,0.00013009364,0.000115294904,0.00004583251,0.00014991818,0.00023497122,0.008789985],"category_scores_gemma":[0.00003920904,0.0002670601,0.00043576153,0.00044602557,0.000070662325,0.00008157561,0.00003606928,0.00022503172,0.00018379881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030960555,0.0022871713,0.0029127605,0.00032853294,0.00017966604,0.0015379433,0.003317012,0.0000011432086,0.95110977,0.00002041301,0.012942006,0.022267511],"study_design_scores_gemma":[0.019903293,0.00045039642,0.006336254,0.000049070553,0.00005983352,0.000043274664,0.00039133962,0.00014623583,0.4985721,0.000022640606,0.47377217,0.0002533712],"about_ca_topic_score_codex":0.00006177715,"about_ca_topic_score_gemma":0.000050021376,"teacher_disagreement_score":0.46083015,"about_ca_system_score_codex":0.00016250712,"about_ca_system_score_gemma":0.0003979333,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W4205852291","doi":"10.1002/jha2.359","title":"Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network","funders":"","keywords":"Daratumumab; Lenalidomide; Medicine; Bortezomib; Multiple myeloma; Internal medicine; Dexamethasone; Oncology; Neutropenia; Carfilzomib; Chemotherapy","score_opus":0.02396165785600094,"score_gpt":0.26758377684002865,"score_spread":0.24362211898402772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205852291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446195,0.0008167095,0.000034746787,0.00091402326,0.0002488094,0.0024871028,0.00032003093,0.00013491373,0.000581703],"genre_scores_gemma":[0.9935288,0.00006406438,0.0018768541,0.00045538688,0.00014162034,0.0007892123,0.0013856803,0.000115730065,0.0016426552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953925,0.0005634747,0.0008130772,0.0010572426,0.0013163243,0.0008573533],"domain_scores_gemma":[0.9959265,0.0018637902,0.00037091208,0.0012219958,0.00017128907,0.00044552976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075959053,0.00052902364,0.00087190274,0.00023745763,0.00067983754,0.00007416709,0.00035735298,0.00013968593,0.0006466001],"category_scores_gemma":[0.0014210768,0.00033420196,0.00014313599,0.00069840514,0.00031960904,0.00021476373,0.0005028975,0.0010763636,0.000035621808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026308661,0.002149511,0.94059294,0.000046415204,0.0005152994,0.0076170517,0.0013833798,0.000015488378,0.0008470218,0.000012885923,0.0035037783,0.01700756],"study_design_scores_gemma":[0.04709154,0.0034467264,0.9254222,0.00015705795,0.00014716141,0.00037666605,0.0014771447,0.0012221123,0.0006740832,0.00003468842,0.019529779,0.00042085245],"about_ca_topic_score_codex":0.0036501864,"about_ca_topic_score_gemma":0.0075917137,"teacher_disagreement_score":0.02078288,"about_ca_system_score_codex":0.00055249454,"about_ca_system_score_gemma":0.00032760427,"threshold_uncertainty_score":0.999911},"labels":[],"label_agreement":null},{"id":"W4206319885","doi":"10.1002/jha2.375","title":"Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Celgene; Bristol-Myers Squibb","keywords":"Medicine; Rituximab; Internal medicine; Tolerability; Refractory (planetary science); Adverse effect; Diffuse large B-cell lymphoma; Gastroenterology; Clinical endpoint; Neutropenia; Phases of clinical research; Lymphoma; Pharmacodynamics; Oncology; Toxicity; Pharmacology; Clinical trial; Pharmacokinetics","score_opus":0.014674722346112092,"score_gpt":0.2874215979630838,"score_spread":0.2727468756169717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206319885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680364,0.00032420017,0.000004807275,0.000061946936,0.000090931586,0.0015022395,0.000116551404,0.000026009719,0.0010696844],"genre_scores_gemma":[0.9973129,0.00003507405,0.000038412978,0.000058876463,0.000017433495,0.00009617044,0.00009447912,0.000053165535,0.0022935108],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974994,0.00030290644,0.0004907367,0.00037393207,0.0009849813,0.00034806],"domain_scores_gemma":[0.99865466,0.00020762095,0.0002110519,0.0005895407,0.00019141402,0.0001457168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053863093,0.00019939018,0.00058393483,0.0004455869,0.00013460852,0.000009720708,0.00019487267,0.000057680292,0.0001487711],"category_scores_gemma":[0.000084465835,0.00018247728,0.00006526225,0.0005781693,0.00013355972,0.000098987184,0.00024461685,0.00036441852,0.0000060061816],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032858795,0.95826,0.028015956,0.00008660316,0.0001225149,0.000079993595,0.005805792,1.3575914e-7,0.00034678797,0.000036408874,0.00041116666,0.0035487795],"study_design_scores_gemma":[0.96351314,0.0111431535,0.017331023,0.00004063726,0.000093035,0.0000051846905,0.0041493657,0.00012098072,0.00081472896,0.00002723474,0.0025976496,0.00016386097],"about_ca_topic_score_codex":0.0003038869,"about_ca_topic_score_gemma":0.0001616116,"teacher_disagreement_score":0.96022725,"about_ca_system_score_codex":0.00023409525,"about_ca_system_score_gemma":0.00016104565,"threshold_uncertainty_score":0.7441208},"labels":[],"label_agreement":null},{"id":"W4212971766","doi":"10.1002/jha2.394","title":"Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Neutropenia; Rituximab; Lenalidomide; Internal medicine; Follicular lymphoma; Febrile neutropenia; Gastroenterology; Diffuse large B-cell lymphoma; Tolerability; Lymphoma; Refractory (planetary science); Adverse effect; Clinical endpoint; Phases of clinical research; Surgery; Chemotherapy; Clinical trial; Multiple myeloma","score_opus":0.00703040522547299,"score_gpt":0.2307756252306112,"score_spread":0.22374522000513822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212971766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760175,0.0003714202,0.0000023999623,0.000055640143,0.000051296694,0.0016746462,0.000033980097,0.000025328496,0.00018353926],"genre_scores_gemma":[0.9992106,0.000020662357,0.000063631,0.00010761617,0.000008307145,0.00036513116,0.00011083565,0.000040296996,0.00007291036],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980604,0.00017013466,0.00039655372,0.00044513273,0.0006258429,0.00030191304],"domain_scores_gemma":[0.9991432,0.0000847771,0.00020557306,0.00038679547,0.00006866415,0.00011100383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021838146,0.00025474268,0.0005752152,0.0003188728,0.00010806649,0.000013642292,0.00008882604,0.000050505903,0.000018909868],"category_scores_gemma":[0.000018846264,0.00019521272,0.00004031016,0.0004390416,0.000038145066,0.0001281369,0.000106121464,0.00008504448,0.0000035583305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028263726,0.46347582,0.526262,0.00003637936,0.000075033095,0.00050542585,0.002580355,0.0000015342363,0.000008641625,0.000025029527,0.000044683882,0.004158715],"study_design_scores_gemma":[0.5074748,0.010293427,0.47970667,0.00006149984,0.00011323905,0.000009540666,0.0016282372,0.00007500888,0.00019883736,0.000006674163,0.00029772843,0.00013432848],"about_ca_topic_score_codex":0.0006770409,"about_ca_topic_score_gemma":0.0005122622,"teacher_disagreement_score":0.50464845,"about_ca_system_score_codex":0.0006178843,"about_ca_system_score_gemma":0.00012781852,"threshold_uncertainty_score":0.79605436},"labels":[],"label_agreement":null},{"id":"W4214776966","doi":"10.1002/jha2.390","title":"Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying <i>FLT3</i>‐ITD with CN‐LOH at chr13q","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Genome Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Princess Margaret Cancer Foundation","keywords":"NPM1; Biology; Cancer research; Myeloid leukemia; Myeloid; Fms-Like Tyrosine Kinase 3; Flow cytometry; Molecular biology; Tyrosine kinase; Exon; Mutation; Gene; Karyotype; Genetics; Receptor; Chromosome","score_opus":0.027405367209557385,"score_gpt":0.24868758232348206,"score_spread":0.22128221511392468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214776966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783463,0.0010660959,0.00005535221,0.0010518003,0.00022613026,0.0017041841,0.00004577977,0.00031351676,0.0077024796],"genre_scores_gemma":[0.9682866,0.000031287684,0.0011774017,0.00041336002,0.00024619885,0.0004004736,0.00019270118,0.00016358055,0.02908842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996374,0.00024382066,0.00048562136,0.0008115268,0.0011290301,0.0009560062],"domain_scores_gemma":[0.99827003,0.000121972065,0.0002224506,0.00087656226,0.00018384121,0.00032512043],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007512855,0.00037229812,0.00057727244,0.00034634097,0.000888505,0.00007697741,0.00040336206,0.000109608554,0.0012217105],"category_scores_gemma":[0.00010562256,0.00033772527,0.00014936326,0.0009127809,0.00021370171,0.00017868314,0.00076140015,0.0011096963,0.00029888004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010525037,0.00014206153,0.0042945985,0.00027174817,0.00013746935,0.002523337,0.003980034,0.000377002,0.97940314,0.000013292704,0.0074002794,0.00040451658],"study_design_scores_gemma":[0.0072241416,0.002020557,0.0016405114,0.00021460993,0.0002710678,0.0026076722,0.006019839,0.0012467753,0.9476942,0.00004670645,0.030195683,0.00081826624],"about_ca_topic_score_codex":0.0010411636,"about_ca_topic_score_gemma":0.00017881257,"teacher_disagreement_score":0.03170899,"about_ca_system_score_codex":0.0056336573,"about_ca_system_score_gemma":0.0010064193,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W4220754793","doi":"10.1002/jha2.410","title":"Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Flow cytometry; Medicine; Paroxysmal nocturnal hemoglobinuria; Immunology; Cytometry; Disease; Pathology","score_opus":0.05942652984013599,"score_gpt":0.2843031458451432,"score_spread":0.22487661600500722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220754793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499477,0.0051079416,0.00446994,0.0024529647,0.00089704746,0.00073608797,0.0011400598,0.00012284027,0.000078357654],"genre_scores_gemma":[0.9956766,0.000061614795,0.0010990291,0.00048353933,0.000048760867,0.001133556,0.000661714,0.000021390215,0.0008138154],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983962,0.00011024898,0.000509388,0.0004988295,0.000084740845,0.00040058006],"domain_scores_gemma":[0.99885094,0.00061207166,0.00018557881,0.0002690362,0.00004961302,0.000032750548],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032047374,0.00021938124,0.00043523774,0.00007087022,0.0010614137,0.00004027901,0.00027597242,0.00010393637,0.0014702294],"category_scores_gemma":[0.00018050314,0.00020821822,0.000111560286,0.00007341114,0.0001485013,0.00010011853,0.00041283018,0.00017885257,0.000028962948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089996035,0.00027115835,0.6050038,0.00020777408,0.0007726934,0.0005186075,0.0033812341,0.0006785025,0.0008706972,0.0084926905,0.37834132,0.00056159915],"study_design_scores_gemma":[0.0054355008,0.0002960581,0.06883273,0.00019250388,0.00038242908,0.0023475916,0.0015204215,0.0018995134,0.007265438,0.006919569,0.90366846,0.0012397956],"about_ca_topic_score_codex":0.000112514484,"about_ca_topic_score_gemma":0.0001757611,"teacher_disagreement_score":0.536171,"about_ca_system_score_codex":0.00013159824,"about_ca_system_score_gemma":0.00011082745,"threshold_uncertainty_score":0.9994426},"labels":[],"label_agreement":null},{"id":"W4220761695","doi":"10.1002/jha2.421","title":"A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Texture (cosmology); Computer science; Image (mathematics); Artificial intelligence","score_opus":0.04346131077421968,"score_gpt":0.3716677394525217,"score_spread":0.328206428678302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220761695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675487,0.000508988,0.030310694,0.0006877196,0.00011307438,0.00023013877,0.000044445682,0.00008929615,0.00046691604],"genre_scores_gemma":[0.96070147,0.00009550491,0.03837621,0.0003884257,0.00013399441,0.000017512715,0.00009961363,0.000037503505,0.0001497587],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99834883,0.00020958747,0.0003459944,0.0004220608,0.00043562404,0.00023790597],"domain_scores_gemma":[0.9984556,0.00079285813,0.00020325276,0.00024550682,0.00006163633,0.00024114082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005424009,0.00019289905,0.000483585,0.00014750533,0.00029221462,0.000054044227,0.00012705819,0.000038724,0.0001353328],"category_scores_gemma":[0.0028752892,0.00012949883,0.000109326334,0.00038746538,0.00017284717,0.00006454208,0.0001597713,0.0015600554,0.0000022036725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019035762,0.00028121687,0.9570269,0.000034281522,0.00046119446,0.00048242934,0.0020544734,0.0019246045,0.002444403,0.000044415257,0.0010085047,0.03404722],"study_design_scores_gemma":[0.0017008972,0.0005003979,0.1128095,0.00006367604,0.00079898775,0.000067663335,0.003266213,0.8795471,0.000065378605,0.000318924,0.00062983343,0.00023138268],"about_ca_topic_score_codex":0.00050094124,"about_ca_topic_score_gemma":0.000014114829,"teacher_disagreement_score":0.87762254,"about_ca_system_score_codex":0.00005130942,"about_ca_system_score_gemma":0.00012122502,"threshold_uncertainty_score":0.67777514},"labels":[],"label_agreement":null},{"id":"W4221052812","doi":"10.1002/jha2.420","title":"Osteolytic lesion in polycythemia vera: First report and review of literature","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Polycythemia vera; Myelofibrosis; Internal medicine; Myeloproliferative neoplasm; Thrombocytosis; Bone pain; Essential thrombocythemia; Gastroenterology; Myeloid; Bone marrow; Surgery; Platelet","score_opus":0.015955295414443425,"score_gpt":0.2853901931935242,"score_spread":0.2694348977790808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221052812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.873316,0.11373703,9.715359e-7,0.0091877375,0.000106022744,0.00067682954,0.000022892405,0.000015244594,0.002937297],"genre_scores_gemma":[0.98161197,0.015593981,0.00018065925,0.0010592315,0.00004200197,0.00022563606,0.00009861777,0.000012423338,0.0011754623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999138,0.000039156213,0.00028283263,0.00021317526,0.00021993044,0.00010689656],"domain_scores_gemma":[0.99949443,0.00006351353,0.00012559655,0.00022438985,0.00003684791,0.000055235705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022347906,0.00010219223,0.0003348828,0.00006898512,0.00006000919,0.0000044851577,0.000031339823,0.000026454094,0.00041712978],"category_scores_gemma":[0.00013283193,0.00007915096,0.000054542244,0.00024087797,0.000020561474,0.000027906568,0.000071684684,0.00016617343,0.000003040384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005424063,0.0014420721,0.8841812,0.013191269,0.00019343798,0.018960275,0.0041686576,0.0000063013367,0.0007780021,0.0011190184,0.056967456,0.01844992],"study_design_scores_gemma":[0.007889294,0.0028407497,0.6143709,0.042592034,0.00044437294,0.013708401,0.00037611445,0.00008210625,0.01091144,0.00024143602,0.3060112,0.00053199887],"about_ca_topic_score_codex":0.0000267331,"about_ca_topic_score_gemma":0.000012697358,"teacher_disagreement_score":0.26981032,"about_ca_system_score_codex":0.000102479484,"about_ca_system_score_gemma":0.0000647038,"threshold_uncertainty_score":0.45672783},"labels":[],"label_agreement":null},{"id":"W4226159334","doi":"10.1002/jha2.343","title":"Degradation of red blood cell deformability during cold storage in blood bags","year":2021,"lang":"en","type":"article","venue":"eJHaem","topic":"Blood transfusion and management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Vancouver General Hospital; British Columbia Institute of Technology; University of British Columbia","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Mitacs; Canadian Blood Services","keywords":"Red blood cell; Bruise; Cold storage; Blood loss; Chemistry; Biomedical engineering; Medicine; Surgery; Biology; Biochemistry","score_opus":0.010849603503041233,"score_gpt":0.22259724117556437,"score_spread":0.21174763767252314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226159334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342346,0.0002293159,0.000044503064,0.0006252383,0.00008493033,0.00031456238,0.0000039374477,0.00003452992,0.0052394914],"genre_scores_gemma":[0.9960285,0.00013638081,0.0008362491,0.00010411497,0.000023056402,0.000014096162,0.000019111014,0.00001099576,0.0028275372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990999,0.00004276571,0.00028801864,0.00020705147,0.00020798812,0.00015429381],"domain_scores_gemma":[0.9994881,0.000017802364,0.000050272934,0.00031170176,0.00006452525,0.000067563815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018138411,0.0000891637,0.00022208193,0.00008128981,0.000027342625,0.000005449136,0.00004824536,0.00005615604,0.00027387752],"category_scores_gemma":[0.00003474024,0.00008654814,0.00007099175,0.00028064803,0.000021488642,0.00005800565,0.00004258063,0.00013528335,0.000006458777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001373451,0.0032992414,0.09506469,0.0013407081,0.00011055431,0.0005409175,0.00070692005,0.00003131534,0.8974723,0.00045599532,0.000142643,0.0006973373],"study_design_scores_gemma":[0.00536127,0.000097745426,0.19417855,0.00009416712,0.00023533952,0.000020070192,0.00034470964,0.000026869235,0.79880244,0.000015012598,0.00074090046,0.00008291322],"about_ca_topic_score_codex":0.000087856424,"about_ca_topic_score_gemma":0.00024145025,"teacher_disagreement_score":0.09911386,"about_ca_system_score_codex":0.00002458192,"about_ca_system_score_gemma":0.00005944568,"threshold_uncertainty_score":0.35293308},"labels":[],"label_agreement":null},{"id":"W4229444575","doi":"10.1002/jha2.455","title":"Transcriptional profiles define drug refractory disease in myeloma","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Multiple myeloma; Lenalidomide; Medicine; Internal medicine; Refractory (planetary science); Oncology; Drug resistance; Disease; Gene expression profiling; Drug; Carfilzomib; Gene; Gene expression; Cancer research; Biology; Pharmacology; Genetics","score_opus":0.02663950204685158,"score_gpt":0.2924291734670066,"score_spread":0.265789671420155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229444575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924955,0.0014695763,0.000004824456,0.0025802697,0.0000980594,0.0005048346,0.00015629629,0.000050894043,0.0026397572],"genre_scores_gemma":[0.993683,0.000024365305,0.00023988329,0.00023063809,0.00008064978,0.00036882886,0.00041465467,0.000019490699,0.00493851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986788,0.00009736319,0.0001625183,0.00024520795,0.00053368305,0.0002824161],"domain_scores_gemma":[0.99942744,0.000046465455,0.000023684475,0.00020973891,0.00002520038,0.0002674982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015255589,0.00010751789,0.00015897687,0.00016727502,0.00012783849,0.000007818426,0.00008313421,0.000014294608,0.0025886288],"category_scores_gemma":[0.00006036606,0.000095667245,0.00008310926,0.00020551568,0.000043136457,0.000059849594,0.000052941232,0.00027457712,0.0000885996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045982124,0.00304814,0.94370776,0.00018378298,0.00013101024,0.0051524187,0.0011662085,0.00004850584,0.0061060567,0.0020727809,0.009041899,0.024743216],"study_design_scores_gemma":[0.003512118,0.00017407583,0.95708215,0.00002609308,0.000022015673,0.000023041546,0.00017753632,0.00038699628,0.00024508685,0.00031609525,0.037934132,0.00010064972],"about_ca_topic_score_codex":0.00011759518,"about_ca_topic_score_gemma":0.000033468194,"teacher_disagreement_score":0.028892234,"about_ca_system_score_codex":0.00024107027,"about_ca_system_score_gemma":0.0002378683,"threshold_uncertainty_score":0.99832314},"labels":[],"label_agreement":null},{"id":"W4281381512","doi":"10.1002/jha2.466","title":"The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation; Leukemia and Lymphoma Society of Canada","keywords":"Medicine; Internal medicine; Transplantation; Framingham Risk Score; Haematopoiesis; Incidence (geometry); Oncology; Myeloid; Hematology; Hematopoietic stem cell transplantation; Stem cell; Disease; Biology","score_opus":0.015462458136434747,"score_gpt":0.2716811655757686,"score_spread":0.25621870743933384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281381512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576515,0.001618754,0.0001032458,0.0010140366,0.00014758983,0.0009634102,0.000058760812,0.00007063422,0.00025841114],"genre_scores_gemma":[0.99444336,0.00094569835,0.0002464973,0.00022873796,0.000031017305,0.00025594965,0.00012575599,0.00006860102,0.0036543775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734247,0.0003511975,0.0004076068,0.00048016588,0.000823534,0.0005950477],"domain_scores_gemma":[0.9986596,0.0005121493,0.00017211084,0.0004427872,0.000051626575,0.00016170763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011146395,0.0002849423,0.0005200554,0.00018979613,0.00070632325,0.000070734255,0.0002953128,0.0001019524,0.00004387481],"category_scores_gemma":[0.00005390986,0.00019319005,0.00014002534,0.00049856136,0.00012011901,0.00013171596,0.00015299504,0.0009186122,0.000010841329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005137802,0.000080387,0.9885512,0.00010433205,0.00031026438,0.0025901708,0.0031308,0.000081702034,0.0028864238,0.000013119786,0.00019199033,0.0015458306],"study_design_scores_gemma":[0.0059900675,0.00041897176,0.98533773,0.00009309089,0.00058636727,0.0004150235,0.0012275098,0.000086489876,0.0053776316,0.00005476365,0.00012313933,0.00028920686],"about_ca_topic_score_codex":0.00020688058,"about_ca_topic_score_gemma":0.0005269664,"teacher_disagreement_score":0.0054762876,"about_ca_system_score_codex":0.00065619574,"about_ca_system_score_gemma":0.00034339915,"threshold_uncertainty_score":0.78780615},"labels":[],"label_agreement":null},{"id":"W4282841307","doi":"10.1002/jha2.487","title":"Giant circulating malignant cells spotted in feathered edge of blood film","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathology; H&E stain; Biopsy; Medicine; Bone marrow; Periodic acid–Schiff stain; Staining","score_opus":0.02109176144886274,"score_gpt":0.25097937853106256,"score_spread":0.22988761708219982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282841307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617904,0.0012966588,0.0000015600842,0.00033348898,0.00010502373,0.0003304183,0.00002957704,0.000022070684,0.001702183],"genre_scores_gemma":[0.99894875,0.000020200623,0.0004163339,0.0001585176,0.00003187479,0.000082514474,0.000026395452,0.000019168443,0.00029623302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990733,0.000055451863,0.00025721503,0.00019703445,0.00022684192,0.00019011187],"domain_scores_gemma":[0.9995238,0.00007236907,0.00008429245,0.0002457975,0.00001968647,0.00005405274],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015561018,0.000101761114,0.00027821265,0.00010357153,0.00005078017,0.0000036165238,0.000063386666,0.000025366748,0.0009647371],"category_scores_gemma":[0.000019528072,0.00008872788,0.00009562454,0.0002452719,0.000018302848,0.000014805728,0.000071339426,0.00011478893,0.000014140008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018446909,0.0066550425,0.6552174,0.00018318169,0.00044714462,0.007791539,0.0047018295,0.00055522006,0.30228645,0.0005965747,0.0018592018,0.01952198],"study_design_scores_gemma":[0.008532614,0.0007487163,0.82424885,0.00027177396,0.00042255735,0.00039455763,0.0025417616,0.0012841196,0.1586535,0.000115087096,0.0025089928,0.0002774971],"about_ca_topic_score_codex":0.00026366528,"about_ca_topic_score_gemma":0.00001679783,"teacher_disagreement_score":0.16903146,"about_ca_system_score_codex":0.000069557755,"about_ca_system_score_gemma":0.000053069187,"threshold_uncertainty_score":0.9999485},"labels":[],"label_agreement":null},{"id":"W4282983914","doi":"10.1002/jha2.470","title":"Gender disparities in multiple myeloma publications","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine","score_opus":0.08493747201237097,"score_gpt":0.29776315267953574,"score_spread":0.21282568066716478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6511331,0.00029607612,0.000072668125,0.022701155,0.0008106613,0.00021032261,0.00003462719,0.00012587744,0.3246155],"genre_scores_gemma":[0.9903519,0.000014852307,0.00005928482,0.0009065515,0.00008261807,0.000029007962,0.000015042752,0.0000022042334,0.008538514],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991609,0.00010348484,0.000058267455,0.00009083617,0.00043121682,0.00015529408],"domain_scores_gemma":[0.99975544,0.000070765556,0.000016498658,0.00008515602,0.000022864422,0.00004926669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060324225,0.000028368617,0.00004957629,0.00006985019,0.00068211026,0.000034558263,0.0003102202,0.000016671182,0.002141723],"category_scores_gemma":[0.00015221439,0.00003257305,0.000020268977,0.0003286333,0.00013289778,0.00011102103,0.0001293912,0.000119092154,0.000028745299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000080233995,0.00011775608,0.54995084,0.0000054125044,0.0000094823245,0.00001375721,0.059897833,0.00006409094,0.000012146193,0.26617292,0.11775001,0.0059977337],"study_design_scores_gemma":[0.00020576669,0.000009977923,0.15361935,0.0000012721615,0.0000035480666,4.859643e-7,0.10379051,0.000029684667,0.000003604737,0.0022232924,0.74005145,0.000061033512],"about_ca_topic_score_codex":0.0031807574,"about_ca_topic_score_gemma":0.003423332,"teacher_disagreement_score":0.62230146,"about_ca_system_score_codex":0.000101957485,"about_ca_system_score_gemma":0.00008937052,"threshold_uncertainty_score":0.9987705},"labels":[],"label_agreement":null},{"id":"W4289857077","doi":"10.1002/jha2.541","title":"Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Context (archaeology); Interleukin-3 receptor; Hematologic malignancy; Foot (prosody); Malignancy; Incidence (geometry); Neoplasm; Internal medicine; Surgery; Pathology; Myeloid; Biology","score_opus":0.0351358055725589,"score_gpt":0.32778408547556886,"score_spread":0.29264827990300996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289857077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173945,0.0006186698,0.0005193132,0.00070875644,0.00051117537,0.0020849851,0.0001115958,0.00012945161,0.0035765907],"genre_scores_gemma":[0.9698724,0.000011750155,0.0009024807,0.0001869357,0.00016405899,0.0012942494,0.00025757303,0.00009267924,0.027217876],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99748635,0.000102855876,0.00044552973,0.0006472848,0.0006226862,0.00069529127],"domain_scores_gemma":[0.99845093,0.00048304812,0.00010120401,0.0005465412,0.00011584321,0.00030242655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028569755,0.00030797246,0.0005281165,0.00024880035,0.0007330273,0.000042884865,0.000120619705,0.00006085761,0.000548542],"category_scores_gemma":[0.00032641424,0.0002924312,0.00043151254,0.00035303918,0.000059384663,0.000047985028,0.00013347017,0.00021658513,0.000049117276],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015034382,0.0021517214,0.012615851,0.0002622603,0.00062811835,0.9520667,0.0030047614,0.0006246532,0.015132535,0.000088887195,0.0048721996,0.007048826],"study_design_scores_gemma":[0.016841091,0.007531603,0.00014721625,0.000057529407,0.0008531752,0.8465185,0.007749974,0.009297232,0.046275314,0.0002309812,0.063703984,0.0007933723],"about_ca_topic_score_codex":0.00032511842,"about_ca_topic_score_gemma":0.00038522622,"teacher_disagreement_score":0.10554822,"about_ca_system_score_codex":0.0010056136,"about_ca_system_score_gemma":0.00064670667,"threshold_uncertainty_score":0.9999528},"labels":[],"label_agreement":null},{"id":"W4293763388","doi":"10.1002/jha2.486","title":"Lymphoma‐associated acquired von Willebrand syndrome responsive to splenectomy: A case report","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Splenectomy; Pancytopenia; Lymphoma; Hairy cell leukemia; Bone marrow; Pathology; Gastroenterology; Internal medicine; Immunology; Leukemia; Spleen","score_opus":0.01407485282783334,"score_gpt":0.2691724685245513,"score_spread":0.25509761569671796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293763388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949172,0.00025534615,0.0000042947495,0.0017269459,0.0002603676,0.0006890445,0.00011143396,0.0001393483,0.0018959823],"genre_scores_gemma":[0.98741245,0.0000048612897,0.0001141817,0.0010857364,0.000020792591,0.00017881702,0.00022835501,0.000041299027,0.010913506],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99843,0.00010033695,0.00029693902,0.0004201425,0.00038410665,0.0003684859],"domain_scores_gemma":[0.9990764,0.00008167183,0.00011593079,0.00041740204,0.00007045478,0.00023809336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027641724,0.00019169351,0.0004773259,0.0001962812,0.0003474712,0.000016633845,0.00007321233,0.000058958038,0.0007322997],"category_scores_gemma":[0.00030228368,0.00018205453,0.00012915184,0.0005485431,0.00002541306,0.000053661177,0.00014287955,0.00007299767,0.00009687152],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079166977,0.0005713115,0.0050218254,0.00000994945,0.0003646536,0.98299646,0.0010465719,0.000013245127,0.0003545082,0.000012579563,0.0070676017,0.0017496264],"study_design_scores_gemma":[0.009937268,0.0020042995,0.042070027,0.00006246652,0.00036807597,0.9015561,0.001442979,0.00008909141,0.00058522535,0.00015254207,0.041332502,0.00039947408],"about_ca_topic_score_codex":0.0004565782,"about_ca_topic_score_gemma":0.000104927945,"teacher_disagreement_score":0.081440404,"about_ca_system_score_codex":0.00046756564,"about_ca_system_score_gemma":0.00022522347,"threshold_uncertainty_score":0.8018168},"labels":[],"label_agreement":null},{"id":"W4293915832","doi":"10.1002/jha2.559","title":"Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Hôpital Maisonneuve-Rosemont; McGill University; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Canadian Apheresis Group; University of Saskatchewan; Université de Montréal; University of Alberta; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; Ottawa Regional Cancer Foundation","funders":"Amgen Canada; Amgen","keywords":"Carfilzomib; Multiple myeloma; Medicine; Oncology; Internal medicine; Database; Lenalidomide; Computer science","score_opus":0.052499326878677435,"score_gpt":0.3199260177462836,"score_spread":0.2674266908676062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293915832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336505,0.0001299586,0.000018185021,0.0015948405,0.00013780098,0.0018472067,0.0025632316,0.000032532767,0.00031116552],"genre_scores_gemma":[0.99319047,0.000007963306,0.0009413877,0.00026782407,0.00006235055,0.00050418364,0.0043294453,0.000040100716,0.0006562843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960116,0.00043606854,0.00038335822,0.0007301342,0.001605493,0.00083333795],"domain_scores_gemma":[0.99777234,0.00049751526,0.00008156636,0.0008631435,0.00017695683,0.00060848345],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010331881,0.00027345802,0.00039841022,0.00037391478,0.0013271221,0.00007260857,0.00028645954,0.00007165273,0.00039961882],"category_scores_gemma":[0.00088896166,0.00017330912,0.00006692684,0.00048328916,0.0003056406,0.00017886094,0.000425964,0.0010291316,0.000027625045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008044472,0.000612072,0.9878769,0.000017378612,0.0001818617,0.006457503,0.00070500036,0.000007106439,0.00003930272,0.000031573592,0.0005851942,0.0026816488],"study_design_scores_gemma":[0.012621853,0.0003925939,0.981256,0.00006556398,0.000031036467,0.00008118135,0.00057063927,0.0004893298,0.000024606647,0.000009668699,0.0042780773,0.00017944294],"about_ca_topic_score_codex":0.5354039,"about_ca_topic_score_gemma":0.78391504,"teacher_disagreement_score":0.24851114,"about_ca_system_score_codex":0.001145855,"about_ca_system_score_gemma":0.0009044919,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W4294682786","doi":"10.1002/jha2.562","title":"Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Cohort; Amyloidosis; Medicine; Cohort study; Population; Demography; Pediatrics; Internal medicine; Environmental health; Sociology","score_opus":0.047382406400186636,"score_gpt":0.316082898481922,"score_spread":0.26870049208173535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294682786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978257,0.000026997968,0.000005495505,0.00036791718,0.00023403086,0.0012980724,0.00017709578,0.000011616274,0.000053114283],"genre_scores_gemma":[0.99789953,0.00011834076,0.000028112254,0.00064382004,0.000019701596,0.00068525085,0.00049075816,0.000035384342,0.000079091486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976568,0.00039346516,0.0006073558,0.00065593165,0.0003324116,0.00035401428],"domain_scores_gemma":[0.9990802,0.0002233158,0.00017122237,0.00039217898,0.000015918113,0.0001172072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026305375,0.0002840181,0.0004993164,0.00018143472,0.00013959194,0.00001933912,0.00015302509,0.000047241327,0.000064065396],"category_scores_gemma":[0.00007670218,0.000269044,0.00010565551,0.0002128095,0.00002164995,0.0000067497904,0.00017988948,0.00013578865,7.8663015e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008105916,0.0017028168,0.9969944,0.0000032062803,0.00018715681,0.00007468505,0.000081832906,0.00022982777,0.0000020975936,0.000004332122,0.0002465334,0.000392083],"study_design_scores_gemma":[0.005430328,0.0007258582,0.992345,0.000007705203,0.00006888091,3.728779e-7,0.00092514046,0.00006082685,0.000032077147,0.0000044811545,0.00014668363,0.00025266764],"about_ca_topic_score_codex":0.8426832,"about_ca_topic_score_gemma":0.98857903,"teacher_disagreement_score":0.14589587,"about_ca_system_score_codex":0.002637056,"about_ca_system_score_gemma":0.00031572243,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4295224466","doi":"10.1002/jha2.514","title":"Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Research Foundation of Korea","keywords":"Genetic analysis; Lymphoblastic Leukemia; Medicine; Gene; Genetic testing; Leukemia; Acute lymphocytic leukemia; Philadelphia chromosome; Internal medicine; Oncology; Genetics; Biology; Chromosomal translocation","score_opus":0.0418294937445355,"score_gpt":0.28491996785506835,"score_spread":0.24309047411053286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295224466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864286,0.000017371585,0.011230962,0.0010644661,0.00009595639,0.00087551627,0.00013531011,0.000027707025,0.00012408833],"genre_scores_gemma":[0.9974637,0.0000014191862,0.00040124616,0.0011665664,0.000054322518,0.00020598657,0.00051873707,0.00004088208,0.00014711582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972041,0.00029029255,0.00044452713,0.00047198133,0.0011856457,0.00040345785],"domain_scores_gemma":[0.9984932,0.0002678319,0.00017615574,0.00062448485,0.00029870748,0.00013965055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045663616,0.0002255092,0.00047982356,0.00064294966,0.00018719447,0.000029821193,0.00030654564,0.000062355044,0.0002576272],"category_scores_gemma":[0.0001190759,0.00015873973,0.00013301965,0.0026296687,0.00009809236,0.00011110851,0.00021107106,0.00034713765,0.000016365131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067287795,0.0014236567,0.6296957,0.0001581025,0.00682019,0.0009316034,0.010639548,0.29543072,0.033733666,0.000099128774,0.006554414,0.007784469],"study_design_scores_gemma":[0.016200703,0.0040145293,0.59846365,0.0001529474,0.0034541525,0.00004237505,0.0015425062,0.3585717,0.016741928,0.000008632503,0.00021103056,0.00059583574],"about_ca_topic_score_codex":0.0010815705,"about_ca_topic_score_gemma":0.00023965866,"teacher_disagreement_score":0.063140966,"about_ca_system_score_codex":0.005294412,"about_ca_system_score_gemma":0.0018801484,"threshold_uncertainty_score":0.99852407},"labels":[],"label_agreement":null},{"id":"W4297100560","doi":"10.1002/jha2.574","title":"Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Cytokeratin; Pathology; Expression (computer science); Plasma cell; Medicine; Immunohistochemistry; Computer science","score_opus":0.025660107102862133,"score_gpt":0.2948468456899351,"score_spread":0.2691867385870729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297100560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972395,0.00022731502,0.000053942487,0.00031427282,0.00008479106,0.0011203404,0.0001096041,0.000020637817,0.0008296137],"genre_scores_gemma":[0.9954309,0.000021006617,0.0019023033,0.000053560874,0.000029489762,0.00070846285,0.00012171854,0.000022711756,0.0017098524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877363,0.00007633874,0.00025850962,0.00023520691,0.0003516438,0.00030467618],"domain_scores_gemma":[0.9989052,0.00063676544,0.000069106056,0.00022603231,0.000035369587,0.00012755583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018459804,0.00011794832,0.00026840676,0.0001553878,0.00009367448,0.0000048173465,0.00009650722,0.000034267636,0.000397384],"category_scores_gemma":[0.0003652729,0.000099897115,0.000074790034,0.00015785395,0.000030823558,0.000036467947,0.000101453166,0.00018376565,0.000015499967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009809833,0.008279364,0.41131616,0.0015731388,0.00016574428,0.0023992343,0.011019354,0.002362713,0.5005832,0.000122026475,0.03350326,0.018866016],"study_design_scores_gemma":[0.04416183,0.006919086,0.10900723,0.00039207196,0.0001264017,0.000119451586,0.004916467,0.021185683,0.79140884,0.00016546473,0.021111792,0.00048566362],"about_ca_topic_score_codex":0.00023045269,"about_ca_topic_score_gemma":0.00011780838,"teacher_disagreement_score":0.30230892,"about_ca_system_score_codex":0.00013618787,"about_ca_system_score_gemma":0.00014355278,"threshold_uncertainty_score":0.43510762},"labels":[],"label_agreement":null},{"id":"W4298143191","doi":"10.1002/jha2.572","title":"Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Dalhousie University; University of Calgary; Institute of Cancer Research; Vancouver General Hospital; CancerCare Manitoba","funders":"Karyopharm Therapeutics","keywords":"Multiple myeloma; Chimeric antigen receptor; Medicine; Antigen; Oncology; Antibody; Immunology; Internal medicine; T cell; Pharmacology; Immune system","score_opus":0.011667212519135682,"score_gpt":0.24987602520445354,"score_spread":0.23820881268531785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298143191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973065,0.00013149362,0.000020936306,0.00033187872,0.000067756904,0.001674494,0.00011521135,0.000060102917,0.00029159896],"genre_scores_gemma":[0.99580204,0.000009338503,0.0016373257,0.00016272931,0.000047990376,0.00047392235,0.0007609081,0.000042538675,0.0010632032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821013,0.00011512031,0.0002413008,0.0004151129,0.0005935395,0.00042477134],"domain_scores_gemma":[0.9991976,0.00006363229,0.00007860477,0.0004029491,0.000078772006,0.00017845706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093771916,0.00023195827,0.00030837578,0.00023333228,0.00015919782,0.000021777709,0.0000749423,0.000044013403,0.0004981385],"category_scores_gemma":[0.000025059286,0.00016798571,0.00007672946,0.0003218192,0.00003520254,0.000085527965,0.000052906544,0.00017107325,0.000068075235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323317,0.002370871,0.9856981,0.000031243653,0.000071062685,0.0007505745,0.00043445476,0.00014390044,0.0003394907,7.3788885e-7,0.00019555431,0.0046407124],"study_design_scores_gemma":[0.01894547,0.0022730504,0.9694644,0.00003255617,0.00003895896,0.0000075047,0.00010239008,0.0025247647,0.0034049384,0.0000010512458,0.0030387687,0.00016612255],"about_ca_topic_score_codex":0.00021572788,"about_ca_topic_score_gemma":0.00013519752,"teacher_disagreement_score":0.016233658,"about_ca_system_score_codex":0.00057214976,"about_ca_system_score_gemma":0.0002020838,"threshold_uncertainty_score":0.6850259},"labels":[],"label_agreement":null},{"id":"W4302292678","doi":"10.1002/jha2.587","title":"COVID‐19 infection and pain in adolescents with sickle cell disease: A case series","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"American Lebanese Syrian Associated Charities","keywords":"Medicine; Disease; Coronavirus disease 2019 (COVID-19); Psychological intervention; Chronic pain; Pediatrics; Physical therapy; Internal medicine; Psychiatry; Infectious disease (medical specialty)","score_opus":0.006607809058895147,"score_gpt":0.22530988699847465,"score_spread":0.2187020779395795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302292678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967514,0.0011001951,0.000051767587,0.0013682215,0.000051602594,0.00031850266,0.00000784377,0.000050278115,0.00030015517],"genre_scores_gemma":[0.99821097,0.000090723624,0.000020356129,0.0010167882,0.000016723872,0.000038816943,0.000013453702,0.000013688967,0.00057846477],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936914,0.000100311925,0.00009565512,0.00016488045,0.00012395866,0.00014602218],"domain_scores_gemma":[0.9995746,0.000008312175,0.000028005461,0.00011071571,0.0000101891,0.00026814637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020888558,0.00008417534,0.00011106799,0.00007714879,0.000166277,0.000007865618,0.00001589778,0.00002692856,0.00011524875],"category_scores_gemma":[0.00005956524,0.00006940364,0.000020225983,0.00021255444,0.000051104034,0.000043109983,0.000042703094,0.00021530737,0.0000031218583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001479098,0.0006684112,0.9399294,0.0009996876,0.000018966277,0.044354424,0.0026993265,0.0008316012,0.00009999397,0.0000353747,0.0020934397,0.0067902794],"study_design_scores_gemma":[0.05445963,0.013818482,0.29397112,0.0019540251,0.000983078,0.096355,0.058859296,0.010628495,0.00033423956,0.0008931461,0.4651445,0.0025990081],"about_ca_topic_score_codex":0.00069305045,"about_ca_topic_score_gemma":0.00029608252,"teacher_disagreement_score":0.64595824,"about_ca_system_score_codex":0.000101337595,"about_ca_system_score_gemma":0.00016491555,"threshold_uncertainty_score":0.28301984},"labels":[],"label_agreement":null},{"id":"W4306921860","doi":"10.1002/jha2.591","title":"Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Adverse effect; Internal medicine","score_opus":0.008993993547951244,"score_gpt":0.22962069161456786,"score_spread":0.2206266980666166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306921860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972619,0.00007286615,0.000005320683,0.0005770094,0.00009201431,0.00070418586,0.00054312986,0.00001810383,0.00072548207],"genre_scores_gemma":[0.99889773,0.000016088272,0.00024507247,0.00022024581,0.000022410146,0.00015124118,0.00020373639,0.000019804731,0.00022365035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817675,0.00026052736,0.00039357052,0.00031832032,0.0006160169,0.00023481475],"domain_scores_gemma":[0.9990407,0.00013284339,0.00020126003,0.00042571742,0.00012001726,0.000079433274],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022213403,0.00018280162,0.0005660461,0.00024950615,0.00020190705,0.000008295795,0.000108049986,0.000039357994,0.0009798608],"category_scores_gemma":[0.00008152575,0.0001120769,0.0002112336,0.001777648,0.00007227756,0.000043771026,0.00013308895,0.00025748814,0.0000040588534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007409644,0.0011058272,0.9917632,0.000014080631,0.0008799247,0.000010019343,0.00089573214,0.00039607962,0.000016240398,0.00008068552,0.0004506102,0.0036466508],"study_design_scores_gemma":[0.004523396,0.0007777386,0.98964393,0.000046930007,0.0015453945,0.000001095034,0.00044363725,0.00018942294,0.0010622157,0.0000056019007,0.0016443513,0.000116285395],"about_ca_topic_score_codex":0.00046028293,"about_ca_topic_score_gemma":0.0006569908,"teacher_disagreement_score":0.0037824316,"about_ca_system_score_codex":0.000230973,"about_ca_system_score_gemma":0.00008069168,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W4308347907","doi":"10.1002/jha2.607","title":"Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hypertriglyceridemia; Medicine; Asparaginase; Lymphoblastic Leukemia; Acute pancreatitis; Gastroenterology; PEG ratio; Internal medicine; Regimen; Incidence (geometry); Pancreatitis; Leukemia; Cholesterol; Triglyceride","score_opus":0.015787965593034924,"score_gpt":0.24534890905523618,"score_spread":0.22956094346220127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308347907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929852,0.00046382035,0.00022739459,0.001852147,0.00008549438,0.0014078395,0.00012675585,0.00035010968,0.0025012454],"genre_scores_gemma":[0.99556386,0.0000960321,0.0020005975,0.00059006753,0.00030728147,0.00021284325,0.00018877997,0.00018167548,0.00085887115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557453,0.0002744673,0.00077756186,0.0010379989,0.0015684109,0.00076704007],"domain_scores_gemma":[0.9971204,0.00031013766,0.0006815223,0.0011700026,0.00028505913,0.00043292565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005023582,0.0006400429,0.0012949147,0.00034670113,0.0003922524,0.000023379842,0.00038566915,0.00013670581,0.00031712567],"category_scores_gemma":[0.0000654018,0.0004860277,0.00014229454,0.0010517748,0.00014494732,0.000221346,0.00017773958,0.00070110115,0.00001311698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36599252,0.0032603424,0.44713113,0.005141235,0.0115228435,0.016774686,0.11414399,0.014280751,0.0020433331,0.0005149988,0.012422756,0.006771422],"study_design_scores_gemma":[0.28292212,0.08323862,0.4510171,0.009723479,0.020581363,0.028034871,0.08242949,0.00927755,0.0117363725,0.00015466037,0.010818689,0.010065696],"about_ca_topic_score_codex":0.002177064,"about_ca_topic_score_gemma":0.0005034487,"teacher_disagreement_score":0.0830704,"about_ca_system_score_codex":0.001246526,"about_ca_system_score_gemma":0.0018727771,"threshold_uncertainty_score":0.99975914},"labels":[],"label_agreement":null},{"id":"W4309350238","doi":"10.1002/jha2.611","title":"Improved donor chimerism in relapse myelofibrosis post allogenic stem cell transplant with azacitidine and oral decitabine—First case report","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Decitabine; Medicine; Azacitidine; Myelofibrosis; Context (archaeology); Oncology; Internal medicine; Stem cell; Myeloid leukemia; Bone marrow","score_opus":0.010410219276091015,"score_gpt":0.22342727244906854,"score_spread":0.21301705317297753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309350238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995597,0.0007905615,0.000023442739,0.001715827,0.00010680853,0.0010926994,0.00018206243,0.000057769965,0.00043382347],"genre_scores_gemma":[0.9964627,0.00014570823,0.00096690515,0.0003292154,0.000046454734,0.00062614377,0.00021385544,0.000055188455,0.0011538173],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980953,0.00008609131,0.0004868328,0.00064054993,0.0002903617,0.0004008839],"domain_scores_gemma":[0.9990166,0.00012396662,0.00015113456,0.00039100836,0.000063097,0.00025421515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026866767,0.00033536853,0.0005763868,0.00017380467,0.00030317134,0.00002679786,0.000064659915,0.00006883012,0.00027239072],"category_scores_gemma":[0.000009246691,0.00025811556,0.00009869463,0.0002945654,0.00007167483,0.00008633264,0.00006959999,0.00033375167,0.000005659427],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048181103,0.002754988,0.47495496,0.00035064828,0.00061868643,0.4849945,0.0104556205,0.00010027471,0.0157337,0.000119756194,0.00060929824,0.004489458],"study_design_scores_gemma":[0.044151556,0.019781005,0.23138067,0.00049116253,0.0019157581,0.5981793,0.008890294,0.0015122265,0.07234044,0.000022914312,0.019275157,0.0020595232],"about_ca_topic_score_codex":0.0012735637,"about_ca_topic_score_gemma":0.0022866237,"teacher_disagreement_score":0.24357429,"about_ca_system_score_codex":0.00020127522,"about_ca_system_score_gemma":0.00014754287,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W4311816595","doi":"10.1002/jha2.622","title":"Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pregnancy; Medicine; Essential thrombocythemia; Cohort; Obstetrics; Early Pregnancy Loss; Aspirin; Antiphospholipid syndrome; Thrombosis; Gynecology; Internal medicine; Abortion; Polycythemia vera; Biology; Genetics","score_opus":0.018943475649943357,"score_gpt":0.3028540981848966,"score_spread":0.28391062253495325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311816595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996533,0.000058832073,0.000004991635,0.00023078753,0.000058502737,0.0011668409,0.00016130114,0.000022482802,0.0017632716],"genre_scores_gemma":[0.99853826,0.0000046646855,0.0002875515,0.000108772976,0.000013725145,0.0004902975,0.00020348642,0.000025694793,0.00032756536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859524,0.000085890904,0.00033995506,0.0002889907,0.00045848216,0.00023142259],"domain_scores_gemma":[0.9992678,0.0001224982,0.00014264575,0.0002565658,0.000112814894,0.000097632605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006430942,0.00020432816,0.00042552798,0.0002224329,0.00011726947,0.00000740319,0.00006358122,0.000030050911,0.0007248776],"category_scores_gemma":[0.000055575787,0.00013917976,0.0001156171,0.00039408565,0.0000445823,0.00006101013,0.000041605137,0.00023745043,0.000019865238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008122343,0.0026313998,0.99111396,0.00001824776,0.00019081835,0.000062335086,0.0016521006,0.0012251595,0.0000070379124,0.0005836928,0.00011473189,0.001588302],"study_design_scores_gemma":[0.006571405,0.0078470595,0.9846293,0.00012049549,0.000056304438,0.000006655885,0.00013576845,0.00006417742,0.00035373936,0.000047029916,0.000040483344,0.0001275888],"about_ca_topic_score_codex":0.00009164584,"about_ca_topic_score_gemma":0.000039117618,"teacher_disagreement_score":0.0064846477,"about_ca_system_score_codex":0.00040537753,"about_ca_system_score_gemma":0.00018068333,"threshold_uncertainty_score":0.79369015},"labels":[],"label_agreement":null},{"id":"W4316019275","doi":"10.1002/jha2.643","title":"Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Disease; Antibody; Immunology; Internal medicine","score_opus":0.018534654225665095,"score_gpt":0.2906267425244382,"score_spread":0.2720920882987731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316019275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429196,0.00038623446,0.000007108152,0.0019906147,0.00008915607,0.0002938166,0.000028800392,0.00016712681,0.0027451676],"genre_scores_gemma":[0.9971311,0.0012431093,0.000033934175,0.00026144492,0.000025977828,0.00000919093,0.00013545122,0.00001898701,0.0011408118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913114,0.000039107366,0.00023547265,0.00023166942,0.00014079576,0.0002218049],"domain_scores_gemma":[0.9993953,0.0001265962,0.000052799205,0.0001830444,0.00004037494,0.00020186653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019188644,0.00010229232,0.00022352277,0.000087378416,0.000074217736,0.000010976945,0.000044395605,0.00008665214,0.000019192032],"category_scores_gemma":[0.00014118069,0.000076464385,0.00004657717,0.0004390659,0.00018773618,0.000036971636,0.000030423424,0.00021925644,0.00005973556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006951636,0.00027123562,0.99426496,0.000031754433,0.00004411961,0.00009419651,0.0003197938,0.000018324678,0.000031060816,0.000038936752,0.0043193144,0.000496791],"study_design_scores_gemma":[0.0018482826,0.00013565036,0.9935426,0.00016764078,0.00009085234,0.0000024824035,0.0004057462,0.0014799992,0.00002100757,0.000036413454,0.0021734207,0.00009590294],"about_ca_topic_score_codex":0.000036856924,"about_ca_topic_score_gemma":0.0000393267,"teacher_disagreement_score":0.0028391175,"about_ca_system_score_codex":0.000020254241,"about_ca_system_score_gemma":0.00007716084,"threshold_uncertainty_score":0.31181273},"labels":[],"label_agreement":null},{"id":"W4327967156","doi":"10.1002/jha2.678","title":"A case of multiple myeloma with AL amyloidosis showing giant Russel bodies","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"","keywords":"Pathology; Medicine; Serum protein electrophoresis; Bone marrow; Biopsy; Immunoglobulin D; Hypogammaglobulinemia; Multiple myeloma; Plasmacytosis; Antibody; Immunology; Monoclonal; Monoclonal antibody","score_opus":0.02109788478399764,"score_gpt":0.26839356898506334,"score_spread":0.2472956842010657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327967156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792516,0.00040759039,0.00009962139,0.0006441239,0.00009836654,0.00024359739,0.0000895276,0.000069232956,0.00042280115],"genre_scores_gemma":[0.9969578,0.00023725629,0.0013883454,0.0002975226,0.00007867791,0.00012079093,0.0001118283,0.00004975169,0.00075806025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876255,0.000047349786,0.000242251,0.0004254603,0.00015266253,0.00036972365],"domain_scores_gemma":[0.99918556,0.00007367124,0.000110687084,0.00046134152,0.00006616411,0.00010255461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012211055,0.00024649047,0.0002805477,0.000096095966,0.00012356878,0.000019821151,0.00015621347,0.00010950057,0.000028306404],"category_scores_gemma":[0.00012063691,0.0001995421,0.00014775772,0.00018514456,0.00012593287,0.000007349839,0.00016769048,0.00007202865,0.000049708935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003955502,0.00043643182,0.40762463,0.00013878875,0.0013106369,0.003735554,0.0018922107,0.0003463098,0.5432189,0.00011208887,0.026196033,0.014592869],"study_design_scores_gemma":[0.002799955,0.0008810053,0.06873009,0.00009243789,0.00020505494,0.0008702573,0.0027639472,0.0003755015,0.90818524,0.000020812031,0.0144058345,0.00066984096],"about_ca_topic_score_codex":0.00020681857,"about_ca_topic_score_gemma":0.0005692026,"teacher_disagreement_score":0.36496636,"about_ca_system_score_codex":0.000023305862,"about_ca_system_score_gemma":0.000052228505,"threshold_uncertainty_score":0.8137091},"labels":[],"label_agreement":null},{"id":"W4376139173","doi":"10.1002/jha2.697","title":"SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; St. Baldrick's Foundation","keywords":"Medicine; Internal medicine; Leukemia; Asymptomatic; Lymphoma; Lymphoblastic Leukemia; Lymphoblastic lymphoma; Disease; Adverse effect; Oncology; Pediatrics; Immunology; T cell","score_opus":0.03128303418584649,"score_gpt":0.35237399374308703,"score_spread":0.32109095955724054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376139173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178374,0.000028940638,0.000035940015,0.003333151,0.00084264786,0.0020725087,0.00010066169,0.00020693241,0.0015954877],"genre_scores_gemma":[0.9957285,0.0003041542,0.000018890963,0.0030045363,0.0003363858,0.00013334614,0.00010891277,0.000045726654,0.00031952682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761385,0.00042467477,0.00050586474,0.0003979641,0.00046884787,0.0005887831],"domain_scores_gemma":[0.9977586,0.0012515138,0.00019880939,0.00050380797,0.000091689144,0.00019555971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009070726,0.00025513204,0.00056750793,0.00044549053,0.00027770913,0.000028365235,0.00015084259,0.0002408675,0.0001080303],"category_scores_gemma":[0.0012805711,0.00017847602,0.00017358952,0.0009731966,0.000089235546,0.00006268137,0.00009168884,0.000618138,0.0005055566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116478905,0.006343896,0.57618535,0.00038224753,0.0011152967,0.00067305757,0.010941884,0.00047332622,0.0013629125,0.00091827003,0.20608433,0.07904054],"study_design_scores_gemma":[0.14970595,0.019804904,0.8065411,0.00021134889,0.00037638782,0.000016956412,0.00018991773,0.00025385435,0.00077537895,0.00047744755,0.021243293,0.00040345665],"about_ca_topic_score_codex":0.0011516417,"about_ca_topic_score_gemma":0.00090662873,"teacher_disagreement_score":0.23035577,"about_ca_system_score_codex":0.00203358,"about_ca_system_score_gemma":0.001388782,"threshold_uncertainty_score":0.7278041},"labels":[],"label_agreement":null},{"id":"W4385552858","doi":"10.1002/jha2.759","title":"Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of British Columbia; BC Cancer Agency","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Medicine; Lenalidomide; Internal medicine; Complete response; Placebo; Multiple myeloma; Dexamethasone; Post-hoc analysis; Gastroenterology; Progression-free survival; Thalidomide; Surgery; Overall survival; Chemotherapy; Pathology","score_opus":0.030003690192812987,"score_gpt":0.2978154897159701,"score_spread":0.26781179952315715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385552858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965136,0.000018211225,6.969553e-7,0.0006709124,0.00005557852,0.0025817202,0.00008469367,0.00005072897,0.000023868419],"genre_scores_gemma":[0.9991111,0.000006566853,0.00008759796,0.00004834989,0.000016747985,0.00023557928,0.00007547467,0.00003696867,0.00038159432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970546,0.0010421186,0.00039571623,0.00034952036,0.0006523426,0.00050574174],"domain_scores_gemma":[0.99423134,0.0048877764,0.00019634278,0.00039791054,0.00013632707,0.00015031088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014231985,0.00025232256,0.0006084186,0.00043285737,0.000072457646,0.000029279163,0.00014457645,0.00011671666,0.000009378527],"category_scores_gemma":[0.0065987054,0.00014252483,0.00006840944,0.00088749576,0.00011703308,0.00010315763,0.000061955274,0.00029714225,0.0000080621785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46863195,0.000505375,0.5282649,0.000007852471,0.00015469987,0.0005405589,0.0012810946,0.000007084752,0.000096630945,2.144101e-7,0.0000148561485,0.00049478246],"study_design_scores_gemma":[0.29391575,0.0062318016,0.69867027,0.000110087385,0.00003959106,5.658294e-7,0.00051332085,0.00027341518,0.00013281338,0.0000011459648,0.00000791714,0.00010331004],"about_ca_topic_score_codex":0.0006096145,"about_ca_topic_score_gemma":0.003998822,"teacher_disagreement_score":0.1747162,"about_ca_system_score_codex":0.0001393255,"about_ca_system_score_gemma":0.00020187385,"threshold_uncertainty_score":0.78997433},"labels":[],"label_agreement":null},{"id":"W4385655472","doi":"10.1002/jha2.760","title":"Empowering patients with sickle cell anemia and their families through innovative educational methods","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Focus group; Thematic analysis; Family medicine; Sickle cell anemia; Disease; Pediatrics; Psychology; Qualitative research; Internal medicine","score_opus":0.011843940729597834,"score_gpt":0.3107433813331093,"score_spread":0.2988994406035115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385655472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794674,0.00029406286,0.00036110572,0.001171279,0.00015641015,0.00022903664,0.0000094135385,0.000074856944,0.018236417],"genre_scores_gemma":[0.9909804,0.00016337355,0.006460808,0.0004430144,0.00005089662,0.00001757108,0.000115665316,0.00002621964,0.0017420816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935865,0.000028277878,0.00013267249,0.00019089443,0.00010590701,0.00018357926],"domain_scores_gemma":[0.9995419,0.00010476764,0.000045499888,0.00013089545,0.0001281227,0.00004880659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105590625,0.00012479043,0.0001683332,0.00007563325,0.00009708818,0.000010923881,0.00003769547,0.000068361325,0.0000646735],"category_scores_gemma":[0.00005251637,0.00007982453,0.000019286983,0.00068333524,0.00010478718,0.00007513704,0.000044938748,0.00016855946,0.000032087584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069268007,0.0012206458,0.653412,0.0010547268,0.00049525325,0.000043933025,0.13008879,0.00018006774,0.011897319,0.003232188,0.042263914,0.15541849],"study_design_scores_gemma":[0.006341154,0.0010655845,0.84620625,0.00039605025,0.000091819165,0.00002391862,0.0444186,0.00029734577,0.018273111,0.0022692806,0.07992429,0.00069260417],"about_ca_topic_score_codex":0.00003681716,"about_ca_topic_score_gemma":0.000002167558,"teacher_disagreement_score":0.19279425,"about_ca_system_score_codex":0.000023863484,"about_ca_system_score_gemma":0.00009534513,"threshold_uncertainty_score":0.32551497},"labels":[],"label_agreement":null},{"id":"W4386000656","doi":"10.1002/jha2.771","title":"Molecular characterization and clonal evolution in Richter transformation: Insights from a case of plasmablastic lymphoma (RT‐PBL) arising from chronic lymphocytic leukaemia (CLL) and review of the literature","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Plasmablastic lymphoma; Immunophenotyping; Lymphoma; Chronic lymphocytic leukemia; Pathology; Lymphocytosis; Context (archaeology); Bone marrow; Aggressive lymphoma; Leukemia; Internal medicine; Immunology; Rituximab; Flow cytometry; Biology","score_opus":0.008715977351772661,"score_gpt":0.2558249163241052,"score_spread":0.24710893897233255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386000656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97413623,0.024468321,0.00031383528,0.00019587658,0.000092770024,0.0006184343,0.00010658053,0.000022375805,0.00004559172],"genre_scores_gemma":[0.9949127,0.0044370457,0.00005930674,0.00012305098,0.00007558031,0.000025118097,0.00032190862,0.000022139997,0.000023161367],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99838316,0.00015011756,0.0005545646,0.00029998744,0.00039807384,0.00021409312],"domain_scores_gemma":[0.99907947,0.00020722703,0.00017045817,0.00033641062,0.000118691954,0.000087725435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018031594,0.00018358976,0.00044603457,0.00019641088,0.000057880403,0.000021726051,0.000089828056,0.00015817962,0.00002096943],"category_scores_gemma":[0.00017412686,0.0001363581,0.00007501361,0.00092181185,0.00015206933,0.00020554288,0.0000853126,0.00014545978,0.0000054153975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020896047,0.00041354212,0.005206711,0.060238164,0.0011724425,0.010495112,0.05144211,0.00074064103,0.7672261,0.0036183302,0.0002728315,0.09708444],"study_design_scores_gemma":[0.06154796,0.00062633306,0.20010865,0.11419779,0.0011051625,0.0055151656,0.000816188,0.52429557,0.08782229,0.0021793055,0.0009076629,0.00087794714],"about_ca_topic_score_codex":0.0010199739,"about_ca_topic_score_gemma":0.00014942445,"teacher_disagreement_score":0.6794038,"about_ca_system_score_codex":0.0061082537,"about_ca_system_score_gemma":0.003028435,"threshold_uncertainty_score":0.9977071},"labels":[],"label_agreement":null},{"id":"W4386162771","doi":"10.1002/jha2.778","title":"Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre","funders":"Lymphoma Research Foundation","keywords":"Survivorship curve; Quality of life (healthcare); Perspective (graphical); Medicine; Young adult; Gerontology; Psychology; Nursing; Environmental health; Computer science","score_opus":0.24786372324723546,"score_gpt":0.458171719905054,"score_spread":0.21030799665781855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386162771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012629498,0.9967724,0.000011606138,0.00035972754,0.00030163693,0.002050859,0.00029624358,0.00003131924,0.000049881295],"genre_scores_gemma":[0.0009053926,0.9983375,0.000048518552,0.00009270382,0.00009189421,0.000099798075,0.00033409876,0.00007287995,0.000017211212],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966085,0.00032604008,0.001299765,0.0008049988,0.0005800059,0.00038070895],"domain_scores_gemma":[0.99806947,0.00032845273,0.00030069734,0.0010809862,0.000038618375,0.00018176695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000803328,0.0005012622,0.00366203,0.0003441992,0.000023210314,0.0000142430035,0.0002729253,0.000135731,0.000009798922],"category_scores_gemma":[0.0007999641,0.000350777,0.00017966772,0.00060570904,0.00013574719,0.000079343496,0.00025632893,0.000279696,0.000012376734],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064511754,0.0008060035,0.01307261,0.7000093,0.00017980824,0.00024544058,0.0005839925,6.7680324e-9,3.0878873e-9,0.00013138256,0.0002124541,0.2846945],"study_design_scores_gemma":[0.0029760355,0.00024231509,0.0030451997,0.9441902,0.0011745663,0.00009771178,0.00034003632,0.000002904737,3.48531e-8,0.000022017359,0.047588386,0.00032061545],"about_ca_topic_score_codex":0.0007302836,"about_ca_topic_score_gemma":0.003745785,"teacher_disagreement_score":0.28437388,"about_ca_system_score_codex":0.001060829,"about_ca_system_score_gemma":0.0007132072,"threshold_uncertainty_score":0.99989444},"labels":[],"label_agreement":null},{"id":"W4387220460","doi":"10.1002/jha2.785","title":"The pathobiology of select adolescent young adult lymphomas","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Spinal Cord Injury BC; BC Cancer Agency","funders":"Servier","keywords":"Lymphoma; Follicular lymphoma; Medicine; Hodgkin lymphoma; Epidemiology; Population; Young adult; Lymphoproliferative disorders; Cancer; Oncology; Internal medicine; Environmental health","score_opus":0.061307852934027456,"score_gpt":0.36014847227096225,"score_spread":0.2988406193369348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113268434,0.9965428,6.769559e-7,0.00010815824,0.0005738095,0.0010989538,0.000056638022,0.000078123085,0.0014275614],"genre_scores_gemma":[0.00029075847,0.99739265,0.000024819792,0.000062860665,0.0002956224,0.00033998725,0.00016317809,0.000066135246,0.0013639794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820405,0.0001582512,0.0006677632,0.0003761604,0.00022196023,0.0003718059],"domain_scores_gemma":[0.99842423,0.00036903398,0.00035720796,0.00061459205,0.00013053187,0.000104427636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002103627,0.00037070276,0.0016612922,0.00009390577,0.000099319266,0.000013148702,0.00019801402,0.00027730566,0.000022763463],"category_scores_gemma":[0.00017705507,0.00018744475,0.00073309615,0.00034498188,0.00008203038,0.000010112058,0.00010036128,0.0001565023,0.0004700488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017281716,0.00024367604,0.0009228071,0.008074858,0.0007451877,0.00023265065,0.000047540863,2.1348669e-8,3.84896e-7,0.0007914339,0.00790556,0.9810186],"study_design_scores_gemma":[0.000800597,0.00025545314,0.0013097438,0.016308334,0.0020223404,0.00042112923,0.000029880108,0.0000013460224,0.000018130222,0.000020990286,0.97863394,0.0001781181],"about_ca_topic_score_codex":0.000116314506,"about_ca_topic_score_gemma":0.000074469244,"teacher_disagreement_score":0.9808405,"about_ca_system_score_codex":0.000379912,"about_ca_system_score_gemma":0.0005838865,"threshold_uncertainty_score":0.76437753},"labels":[],"label_agreement":null},{"id":"W4387220835","doi":"10.1002/jha2.786","title":"Scientific techniques in adolescent and young adult classic Hodgkin lymphoma","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Leukemia and Lymphoma Society; Lymphoma Research Foundation","keywords":"Lymphoma; Hodgkin lymphoma; Genomics; Medicine; Medical physics; Computational biology; Genome; Biology; Internal medicine; Genetics","score_opus":0.0733396494760577,"score_gpt":0.35720715747159715,"score_spread":0.28386750799553945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069264515,0.9956683,0.0000013014538,0.00011471469,0.00051020685,0.0017108198,0.000040601448,0.00023427627,0.0010271538],"genre_scores_gemma":[0.00044442734,0.99603415,0.00019385146,0.000066701585,0.00019761258,0.0006606407,0.00017988699,0.00008537384,0.0021373408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977591,0.000090481146,0.0006066053,0.0007739624,0.00036060918,0.00040926307],"domain_scores_gemma":[0.9989093,0.00007784498,0.00019068096,0.00056274,0.00007892144,0.00018053853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029235875,0.0004568706,0.0015868802,0.00059731974,0.00009253017,0.00012767609,0.00013697936,0.00032115204,0.000018395178],"category_scores_gemma":[0.00009532906,0.00032942893,0.00031920627,0.00076012814,0.0001279705,0.00005352945,0.00015546175,0.0001632643,0.00029492195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006853454,0.00037127125,0.0015836974,0.010319864,0.00009964661,0.00075506524,0.000067921355,1.9150967e-9,5.887584e-7,0.00015777159,0.006333803,0.9803035],"study_design_scores_gemma":[0.0009241326,0.00011840496,0.004495176,0.05935644,0.0007538032,0.00033878832,0.000033679637,0.0000033855442,0.000036435387,0.000028349325,0.9335924,0.00031904108],"about_ca_topic_score_codex":0.00016927223,"about_ca_topic_score_gemma":0.00025062164,"teacher_disagreement_score":0.97998446,"about_ca_system_score_codex":0.00081078196,"about_ca_system_score_gemma":0.00048249055,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W4387519805","doi":"10.1002/jha2.796","title":"A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials","year":2023,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Hazard ratio; Concordance; Medicine; Internal medicine; Confidence interval; Follicular lymphoma; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Nuclear medicine","score_opus":0.0548538705679847,"score_gpt":0.3546498356595077,"score_spread":0.299795965091523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387519805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968914,0.0005191588,1.6428837e-7,0.0012820199,0.000114311806,0.0010681382,0.000069662885,0.0000068069326,0.000048361468],"genre_scores_gemma":[0.9996407,0.00009715752,0.00001793634,0.00006786286,0.000024767982,0.000054833974,0.0000114782515,0.000008114787,0.0000771589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882376,0.0003337407,0.00033577098,0.00015164865,0.00023671628,0.00011837575],"domain_scores_gemma":[0.9983239,0.001011984,0.00022206019,0.00035545108,0.000053724623,0.00003285857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007171082,0.0001077602,0.00040951298,0.000027450318,0.000080093465,0.00001226535,0.000096248645,0.00003764181,0.000021101781],"category_scores_gemma":[0.0004938257,0.00004150644,0.0000421377,0.00015323843,0.00013764719,0.000033798628,0.00008249403,0.000063983,0.0000028778713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055326736,0.0004769196,0.9846682,0.000027857332,0.0000684834,0.000002543199,0.0024624607,0.0000013933959,0.00074991724,0.000002899974,0.00413346,0.0018731941],"study_design_scores_gemma":[0.012166416,0.00082204706,0.9794482,0.00048958487,0.00018494346,0.0000014708035,0.00020998657,0.00017713515,0.0060153618,0.00000707164,0.00043187753,0.000045919547],"about_ca_topic_score_codex":0.00017143127,"about_ca_topic_score_gemma":0.00004933743,"teacher_disagreement_score":0.006633743,"about_ca_system_score_codex":0.000026310468,"about_ca_system_score_gemma":0.0000749761,"threshold_uncertainty_score":0.16925834},"labels":[],"label_agreement":null},{"id":"W4388627795","doi":"10.1002/jha2.814","title":"Cost and cost‐effectiveness of immunotherapy in childhood ALL: A systematic review","year":2023,"lang":"en","type":"review","venue":"eJHaem","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Clofarabine; Immunotherapy; Cost effectiveness; Intensive care medicine; Oncology; Internal medicine; Lymphoblastic Leukemia; Leukemia; Cancer; Risk analysis (engineering)","score_opus":0.08880244641940684,"score_gpt":0.4163653528829996,"score_spread":0.32756290646359276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388627795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006715531,0.98159,0.000025549074,0.00003086247,0.000090518304,0.017937735,0.000057384455,0.000053604374,0.00020763042],"genre_scores_gemma":[0.000008809546,0.9962731,0.000037508587,0.00010481544,0.000042771982,0.0029201845,0.00015969235,0.00014759437,0.00030553978],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959214,0.0012324441,0.0013154808,0.00050370785,0.00059562933,0.00043138035],"domain_scores_gemma":[0.9961221,0.0022785007,0.0004728215,0.0008630831,0.000110753725,0.00015269694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029883147,0.00047286565,0.0062184925,0.0004283501,0.00002220543,0.000015112896,0.00031863138,0.00030068107,0.0000357865],"category_scores_gemma":[0.0015372513,0.00032234957,0.00043261584,0.001016955,0.00011479491,0.000041225765,0.00016012765,0.0005878661,0.00017995841],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021266575,0.00009174728,0.0000029752234,0.93576324,0.00076019973,0.00020533187,0.00007189176,3.3681207e-8,5.9454106e-7,0.00003145944,0.00024657685,0.0628047],"study_design_scores_gemma":[0.0017339652,0.00013826803,0.000043326814,0.9481006,0.0019725114,0.0006126857,0.0000148803165,0.000005799334,0.0000012303519,0.000010858761,0.047141615,0.00022424356],"about_ca_topic_score_codex":0.000085062304,"about_ca_topic_score_gemma":0.0000063960383,"teacher_disagreement_score":0.06258046,"about_ca_system_score_codex":0.0010788722,"about_ca_system_score_gemma":0.0012856626,"threshold_uncertainty_score":0.9999229},"labels":[],"label_agreement":null},{"id":"W4391611819","doi":"10.1002/jha2.854","title":"Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Sierra Oncology; Cancer Research UK","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Bone marrow; Internal medicine; Fibrosis; Oncology","score_opus":0.016644996279522664,"score_gpt":0.2625453157424232,"score_spread":0.24590031946290053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391611819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994898,0.00046219543,0.0000014924889,0.0024586427,0.00013122888,0.0015625709,0.00006838802,0.0001308878,0.00028659607],"genre_scores_gemma":[0.99675435,0.00034108025,0.00049815315,0.0002854738,0.00006700549,0.00046744326,0.00007159887,0.00009509302,0.0014197933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777937,0.00006926875,0.0003952084,0.00067842007,0.00051802496,0.0005597268],"domain_scores_gemma":[0.99898994,0.00031614045,0.00008683571,0.00036305882,0.00007030256,0.00017371892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013447246,0.00045842334,0.00080572773,0.00044530001,0.00007546242,0.00009188982,0.00008513934,0.00012262113,0.0004137755],"category_scores_gemma":[0.000043213106,0.0002562387,0.00008186243,0.0006778715,0.00007884725,0.00014438835,0.000044546792,0.00032342924,0.00006969717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056469766,0.0012455562,0.97727203,0.00019134447,0.00025169816,0.00059936225,0.002475701,0.00002323937,0.0001669539,0.0000653166,0.000067458386,0.011994362],"study_design_scores_gemma":[0.014393417,0.0027874867,0.9733511,0.0020294888,0.00007045909,0.000022081684,0.00015826448,0.0000271636,0.0062324596,0.000004014374,0.00059369043,0.0003303517],"about_ca_topic_score_codex":0.00011738857,"about_ca_topic_score_gemma":0.0006420111,"teacher_disagreement_score":0.01166401,"about_ca_system_score_codex":0.00023544458,"about_ca_system_score_gemma":0.000103599414,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W4391752756","doi":"10.1002/jha2.857","title":"Haemoglobin Ottawa, sickle cell trait and vaso‐occlusive crises","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Occlusive; Sickle cell trait; Vaso-occlusive crisis; Trait; Medicine; Internal medicine; Cardiology; Sickle cell anemia; Computer science; Disease","score_opus":0.009849515160600125,"score_gpt":0.2536262625888375,"score_spread":0.2437767474282374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391752756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82179177,0.029035877,0.00022959485,0.006693977,0.0008590052,0.0005510244,0.00004619112,0.0004427191,0.14034985],"genre_scores_gemma":[0.9826208,0.00071409316,0.00041929784,0.00100675,0.00020808406,0.0000123047785,0.000025077636,0.00004511476,0.014948505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988912,0.000024939334,0.00022083112,0.00035338133,0.00019763396,0.0003120273],"domain_scores_gemma":[0.99945873,0.00007284286,0.000024319952,0.00019901412,0.000039307717,0.00020579781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012386023,0.00019087845,0.0002654354,0.00011186948,0.00010131879,0.00005588866,0.00006335881,0.00017015696,0.0005757464],"category_scores_gemma":[0.000036562305,0.00014762956,0.00011594013,0.0002509802,0.00012495722,0.00008647703,0.000053265434,0.00033368933,0.00029771807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002284664,0.00078091293,0.0048759105,0.0033509682,0.00061311165,0.006482318,0.017782636,0.000065553475,0.032706186,0.008321997,0.75704986,0.16774207],"study_design_scores_gemma":[0.0025351055,0.00067787635,0.005326034,0.00068285014,0.0005979864,0.00077876827,0.004406683,0.0018420302,0.012762618,0.0013403457,0.9684731,0.0005766135],"about_ca_topic_score_codex":0.00011394923,"about_ca_topic_score_gemma":0.00001424717,"teacher_disagreement_score":0.21142323,"about_ca_system_score_codex":0.00004294954,"about_ca_system_score_gemma":0.000121436016,"threshold_uncertainty_score":0.63040197},"labels":[],"label_agreement":null},{"id":"W4393277405","doi":"10.1002/jha2.875","title":"Montreal cognitive assessment in Brazilian adults with sickle cell disease: The burdens of poor sociocultural background","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Montreal Cognitive Assessment; Medicine; Cognition; Internal medicine; Confidence interval; Stroke (engine); Disease; Gerontology; Cognitive impairment; Psychiatry","score_opus":0.006891455362292283,"score_gpt":0.2632693709287501,"score_spread":0.2563779155664578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393277405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752417,0.0036270167,0.000021584276,0.0047525046,0.00010495846,0.00053709483,0.00004462588,0.00004472568,0.015625797],"genre_scores_gemma":[0.9958756,0.00024183771,0.000041580162,0.00022054194,0.00007341528,0.00002570446,0.00006846985,0.000021018079,0.0034318552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99904954,0.00004396999,0.00018896328,0.00023068061,0.00026165575,0.00022518898],"domain_scores_gemma":[0.9995595,0.000092812414,0.00003707686,0.0001262237,0.00007046669,0.00011387051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009666586,0.00014507477,0.00019663594,0.000045820114,0.00005408287,0.000023899986,0.0000617224,0.0000682967,0.00017251832],"category_scores_gemma":[0.000011290933,0.00007547702,0.00008995139,0.00022802698,0.00017064487,0.0000593886,0.000021562118,0.00036027055,0.00003832422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01987067,0.01042704,0.24256629,0.016116787,0.004851707,0.020404166,0.25716475,0.0010761138,0.009269047,0.00674901,0.091441095,0.32006332],"study_design_scores_gemma":[0.013276739,0.0017638436,0.7953682,0.0064024217,0.0013437356,0.0001018805,0.16242696,0.009424311,0.001189755,0.00034506968,0.0076563517,0.00070074806],"about_ca_topic_score_codex":0.0007864026,"about_ca_topic_score_gemma":0.00046987904,"teacher_disagreement_score":0.5528019,"about_ca_system_score_codex":0.00006421519,"about_ca_system_score_gemma":0.00023190893,"threshold_uncertainty_score":0.30778638},"labels":[],"label_agreement":null},{"id":"W4394926574","doi":"10.1002/jha2.895","title":"Concurrent <i>BCR‐ABL1</i> and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; Grand River Hospital; McMaster University","funders":"","keywords":"Chromosomal translocation; Fusion gene; breakpoint cluster region; Myeloid leukemia; Cancer research; Biology; Core binding factor; ABL; Chromosomal rearrangement; Gene rearrangement; Breakpoint; Chromosome; Genetics; Gene; Molecular biology; Karyotype; Receptor; Transcription factor","score_opus":0.028341427139570535,"score_gpt":0.3238172146466163,"score_spread":0.29547578750704573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394926574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81906646,0.17879997,0.000008437719,0.0006180248,0.00019046769,0.0007025306,0.00015019809,0.000045249362,0.00041864184],"genre_scores_gemma":[0.9182669,0.078826636,0.00051295955,0.0004070162,0.00014161464,0.000076331075,0.00023314804,0.000046777874,0.0014885911],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9984325,0.00003794877,0.00051202247,0.0004766862,0.0002460601,0.00029474995],"domain_scores_gemma":[0.99921244,0.00009294802,0.00011189983,0.0003373773,0.00005860995,0.00018671098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003460823,0.00025204182,0.00057648774,0.00016005053,0.00003619552,0.000034285997,0.000046692923,0.00013173567,0.0000906587],"category_scores_gemma":[0.00009247975,0.00019839409,0.000083986335,0.00037093947,0.0000793648,0.00010025115,0.000096595206,0.00041141192,0.0000058831915],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008908605,0.00014348932,0.029680198,0.037997615,0.0009797139,0.8112703,0.0058861403,3.6060496e-7,0.014641294,0.00020215265,0.009363247,0.08974638],"study_design_scores_gemma":[0.009489773,0.0009742211,0.00896112,0.15223746,0.0025090505,0.73460764,0.00043072502,0.00041385402,0.009544575,0.000046138157,0.07995654,0.0008288852],"about_ca_topic_score_codex":0.000107581574,"about_ca_topic_score_gemma":0.000048735612,"teacher_disagreement_score":0.11423985,"about_ca_system_score_codex":0.001203303,"about_ca_system_score_gemma":0.0005538926,"threshold_uncertainty_score":0.8090276},"labels":[],"label_agreement":null},{"id":"W4396534346","doi":"10.1002/jha2.894","title":"Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Memorial University of Newfoundland; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; University of Saskatchewan; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; Juravinski Cancer Centre; McGill University; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Spinal Cord Injury BC; Canadian Apheresis Group; Jewish General Hospital","funders":"","keywords":"Lenalidomide; Bortezomib; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Melphalan; Oncology; Prednisone; Maintenance therapy; Progression-free survival; Cyclophosphamide; Surgery; Chemotherapy","score_opus":0.10700761405325468,"score_gpt":0.41025824185256915,"score_spread":0.30325062779931444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396534346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948145,0.0004812614,0.000031026586,0.0042811134,0.00030010135,0.0027320234,0.0009624684,0.000044651926,0.0016858936],"genre_scores_gemma":[0.99514747,0.00006825295,0.0013693265,0.000092298425,0.00011883938,0.00035319742,0.0025169717,0.000045935303,0.0002876897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99456215,0.00069187995,0.00069415895,0.0007272193,0.0024233973,0.0009011679],"domain_scores_gemma":[0.9955149,0.0025036824,0.000117716256,0.0011946883,0.00031349188,0.00035552046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030882508,0.00034313867,0.0005122915,0.00076872983,0.00048499057,0.0001442992,0.0006282635,0.00012242021,0.00006986636],"category_scores_gemma":[0.002324804,0.00017265708,0.00012415924,0.0015886602,0.00041300192,0.00047469654,0.0001995689,0.0011514494,0.000024074294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001955252,0.0007964225,0.97523236,0.00012990985,0.00031142723,0.013461253,0.0027936564,0.000003799794,0.000052480285,0.00025894254,0.00046524726,0.0045392285],"study_design_scores_gemma":[0.009211554,0.00021276031,0.98680913,0.0014671407,0.00008526132,0.00006236307,0.00042317953,0.00035495765,0.000091269016,0.00002874087,0.0010763876,0.00017725538],"about_ca_topic_score_codex":0.35928726,"about_ca_topic_score_gemma":0.90612507,"teacher_disagreement_score":0.5468378,"about_ca_system_score_codex":0.000749705,"about_ca_system_score_gemma":0.0016595487,"threshold_uncertainty_score":0.70407516},"labels":[],"label_agreement":null},{"id":"W4398142926","doi":"10.1002/jha2.926","title":"Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Héma-Québec; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Interquartile range; Pediatrics; Retrospective cohort study; Poisson regression; Cohort; Logistic regression; Newborn screening; Internal medicine; Population","score_opus":0.005734414841063921,"score_gpt":0.23556998283575584,"score_spread":0.2298355679946919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398142926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952875,0.00024213686,0.00005215728,0.0008743806,0.000019004578,0.0016074463,0.000048799142,0.0000139006315,0.0018546677],"genre_scores_gemma":[0.99960554,0.000011383571,0.000029128609,0.00006308165,0.000014716289,0.000006069469,0.000008588073,0.000015051215,0.00024647234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896306,0.00010779116,0.00022339213,0.00018774798,0.00037699332,0.00014101957],"domain_scores_gemma":[0.9993737,0.00012344985,0.00010243415,0.0002848419,0.000065104316,0.00005048941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000321316,0.00012454658,0.0002861301,0.00009002483,0.0000324254,0.000007367913,0.00012194895,0.000037421963,0.000015239981],"category_scores_gemma":[0.000060491515,0.00005874898,0.00007871623,0.00040378628,0.00017249298,0.00004840411,0.000032221233,0.00030203184,0.0000015293007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006092511,0.0005916046,0.9917232,0.000056885983,0.00023841468,0.00013490902,0.005525209,0.00010988437,0.00008444403,0.00045325994,0.000105976105,0.00036699994],"study_design_scores_gemma":[0.0010303603,0.001258664,0.9884768,0.0003884101,0.0003352642,0.0000032702972,0.007768028,0.00015957424,0.000497084,0.000013305075,0.0000065768954,0.00006262365],"about_ca_topic_score_codex":0.009007885,"about_ca_topic_score_gemma":0.0013442656,"teacher_disagreement_score":0.0076636197,"about_ca_system_score_codex":0.00007120236,"about_ca_system_score_gemma":0.00020884207,"threshold_uncertainty_score":0.9975912},"labels":[],"label_agreement":null},{"id":"W4399922122","doi":"10.1002/jha2.939","title":"Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"eJHaem","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Guelph; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Syk; Thrombocytopenic purpura; Relative risk; Adverse effect; Internal medicine; Placebo; Confidence interval; Meta-analysis; Immune thrombocytopenia; Refractory (planetary science); Gastroenterology; Platelet; Tyrosine kinase","score_opus":0.060072165561391944,"score_gpt":0.37229487270959344,"score_spread":0.3122227071482015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399922122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000065125514,0.98745376,0.000004422131,0.00017647923,0.00004508034,0.011705467,0.00038210262,0.00003812938,0.00018804999],"genre_scores_gemma":[0.00002664882,0.9923315,0.00015429597,0.0002912667,0.000008858105,0.004718297,0.0011765382,0.00007278199,0.0012198009],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972303,0.0001537016,0.0014805839,0.0005861874,0.00024277027,0.00030646133],"domain_scores_gemma":[0.99846673,0.00019920364,0.00048320022,0.000629612,0.00012383454,0.00009741989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034330497,0.0006105787,0.013361163,0.00043268924,0.00003900535,0.000047884834,0.00015169352,0.00019885879,0.000100098696],"category_scores_gemma":[0.00025257366,0.0003423057,0.0028205044,0.0010770076,0.000028080722,0.000067939196,0.00008796806,0.00026405277,0.0001202955],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026679297,0.00012870732,7.39404e-7,0.830723,0.16517657,0.000076799544,0.000038521768,6.893321e-9,2.0578603e-9,0.000045370358,0.0002263847,0.0035812517],"study_design_scores_gemma":[0.0005163417,0.000110800254,0.0000011950003,0.17867425,0.80892783,0.000046814297,0.000012889455,0.0000032545356,3.7550844e-8,0.000027231381,0.011454807,0.00022450968],"about_ca_topic_score_codex":0.000040872663,"about_ca_topic_score_gemma":0.000048195856,"teacher_disagreement_score":0.6520487,"about_ca_system_score_codex":0.00012559514,"about_ca_system_score_gemma":0.00010384982,"threshold_uncertainty_score":0.9999029},"labels":[],"label_agreement":null},{"id":"W4401061016","doi":"10.1002/jha2.987","title":"Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Cryoglobulinemia; Monoclonal gammopathy; Thrombosis; Antiphospholipid syndrome; Retrospective cohort study; Dermatology; Monoclonal; Cryoglobulins; Pathology; Immunology; Internal medicine; Monoclonal antibody; Antibody","score_opus":0.018677415950350117,"score_gpt":0.31941775954252516,"score_spread":0.30074034359217505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401061016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891246,0.0063062203,0.000061069724,0.00025700114,0.0007244566,0.0029188425,0.00002518744,0.00021344169,0.0005813202],"genre_scores_gemma":[0.9973054,0.00027244302,0.00044816107,0.000047055462,0.00023075321,0.00017617576,0.0000114312625,0.00008683099,0.0014217569],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99655426,0.00010814274,0.0006456229,0.0012603721,0.00088144914,0.0005501397],"domain_scores_gemma":[0.9983682,0.0001420731,0.00008028331,0.00072115025,0.00020990982,0.00047836217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012735582,0.00037563147,0.0009782744,0.00032184742,0.00016879683,0.00018665128,0.00010117834,0.00013840452,0.00006643752],"category_scores_gemma":[0.00046156655,0.00032262376,0.00013491129,0.0006063441,0.00012448762,0.00011047061,0.0002891513,0.00054072257,0.00008479364],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008072421,0.00014856253,0.6102733,0.0005279674,0.00057800766,0.38130847,0.0030384988,7.372475e-7,0.0016912872,0.00001973227,0.0018749585,0.0004577435],"study_design_scores_gemma":[0.00078295876,0.0011015759,0.07491583,0.0013384748,0.00040108516,0.9166174,0.003148229,0.0002926968,0.00041878226,0.000022826736,0.00065184926,0.00030828684],"about_ca_topic_score_codex":0.00046171737,"about_ca_topic_score_gemma":0.00008385035,"teacher_disagreement_score":0.5353575,"about_ca_system_score_codex":0.0005826689,"about_ca_system_score_gemma":0.00020258472,"threshold_uncertainty_score":0.9999226},"labels":[],"label_agreement":null},{"id":"W4401785292","doi":"10.1002/jha2.992","title":"Low‐grade follicular lymphoma with interferon regulatory factor‐4 rearrangement: Expanding the spectrum of interferon regulatory factor‐4‐rearranged lymphomas","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"IRF4; Interferon regulatory factors; Lymphoma; Follicular lymphoma; Cancer research; Biology; Transcription factor; BCL6; Gene rearrangement; B cell; Immunology; Genetics; Gene; Antibody; Germinal center","score_opus":0.018431809353097475,"score_gpt":0.2595265361951416,"score_spread":0.24109472684204414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401785292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98746604,0.0066440017,0.00008585988,0.0013865756,0.00072400953,0.0010526589,0.000055000673,0.00031158671,0.0022742664],"genre_scores_gemma":[0.99753565,0.00027369018,0.0000820618,0.00018290829,0.00038462508,0.00013843429,0.000050227172,0.00013679653,0.001215628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996744,0.00014376066,0.00068264594,0.0008397641,0.0009171176,0.00067275035],"domain_scores_gemma":[0.9980126,0.00019195784,0.0002044896,0.0012367547,0.00007632943,0.0002778739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002671081,0.00062318856,0.0008189443,0.000340646,0.00018729153,0.00012839519,0.00032578598,0.00021629749,0.000547036],"category_scores_gemma":[0.000026074431,0.0003783962,0.00048241863,0.00049620896,0.0002771194,0.0002501145,0.00015069298,0.00019373723,0.00010731558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009920145,0.008475153,0.22279492,0.0062929494,0.018461315,0.006798399,0.054335013,0.000068832305,0.3691553,0.01474312,0.024630256,0.2643246],"study_design_scores_gemma":[0.008364302,0.0036983704,0.34400043,0.0048057917,0.0009931148,0.00056302716,0.0019549779,0.00022050845,0.6209404,0.00025425508,0.013363346,0.0008414756],"about_ca_topic_score_codex":0.00024066762,"about_ca_topic_score_gemma":0.00010997876,"teacher_disagreement_score":0.26348314,"about_ca_system_score_codex":0.0012199702,"about_ca_system_score_gemma":0.00030267017,"threshold_uncertainty_score":0.9998668},"labels":[],"label_agreement":null},{"id":"W4402851848","doi":"10.1002/jha2.1009","title":"Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Trisomy; Myeloid leukemia; Chronic lymphocytic leukemia; Medicine; Leukemia; Cancer research; Immunology; Biology; Genetics","score_opus":0.02012030499881464,"score_gpt":0.30768720463350746,"score_spread":0.28756689963469284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402851848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424299,0.04194916,0.0004240468,0.0005351715,0.0014468761,0.0013054606,0.000053165953,0.00089532207,0.010960922],"genre_scores_gemma":[0.9776778,0.0050556236,0.00018123059,0.0003571058,0.0014988784,0.00014965038,0.00009267141,0.00015564014,0.014831386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960954,0.000090044254,0.0006339999,0.0010849222,0.0009714918,0.0011240995],"domain_scores_gemma":[0.99793226,0.00039542813,0.000069640875,0.0008126643,0.00010676702,0.00068322034],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004968393,0.00053457153,0.00080150156,0.00039015026,0.00018996031,0.00022732282,0.000314153,0.00033240058,0.0005817498],"category_scores_gemma":[0.00013929914,0.00044749552,0.0002838801,0.0006032607,0.0005085956,0.00028337436,0.00038487746,0.0007795736,0.0014848422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011264988,0.00013218157,0.000632787,0.009806932,0.0050561787,0.022794986,0.005396979,0.00063732086,0.061279494,0.008003884,0.18872674,0.696406],"study_design_scores_gemma":[0.0413847,0.0016905072,0.0010639876,0.0023680432,0.0014760719,0.012282354,0.00033073855,0.37349963,0.026039653,0.00031965034,0.53826475,0.0012799194],"about_ca_topic_score_codex":0.0009082208,"about_ca_topic_score_gemma":0.00006983778,"teacher_disagreement_score":0.6951261,"about_ca_system_score_codex":0.2021933,"about_ca_system_score_gemma":0.07334689,"threshold_uncertainty_score":0.9997977},"labels":[],"label_agreement":null},{"id":"W4404637258","doi":"10.1002/jha2.1055","title":"Impact of secondary‐type mutations in acute myeloid leukemia with CEBPA mutation","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"CEBPA; NPM1; Myeloid leukemia; Mutation; Oncology; Cancer research; Medicine; Leukemia; Gene mutation; Biology; Genetics; Internal medicine; Gene; Karyotype","score_opus":0.016944622660782407,"score_gpt":0.3350985587325181,"score_spread":0.3181539360717357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404637258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202096,0.00043522954,0.00029995627,0.0005185206,0.00008154802,0.00043822764,0.00004176578,0.00009133457,0.0060724462],"genre_scores_gemma":[0.9959635,0.000059807444,0.0012103943,0.00005226467,0.000083779814,0.00002613619,0.00021406486,0.000046482233,0.0023435734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873614,0.000047349095,0.00028306036,0.00029214707,0.00032969465,0.00031163325],"domain_scores_gemma":[0.99923235,0.00014956288,0.00004340575,0.00027202073,0.00017242473,0.00013025105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021576666,0.00016211296,0.00029907987,0.0004938829,0.000033203814,0.000029850207,0.000096490236,0.0001032765,0.00071509625],"category_scores_gemma":[0.00008038062,0.000118697004,0.000097146934,0.0011889423,0.00013380317,0.00021250977,0.000034163288,0.0005517942,0.00018926922],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096086105,0.0009276076,0.13423756,0.0034644648,0.008168544,0.03318375,0.04727897,0.007005475,0.35566688,0.005090224,0.060735516,0.3346324],"study_design_scores_gemma":[0.009110516,0.00618326,0.9041871,0.0012884949,0.00068402075,0.0037234207,0.0018087481,0.03349699,0.034578826,0.0009843699,0.0032435085,0.000710752],"about_ca_topic_score_codex":0.00067437394,"about_ca_topic_score_gemma":0.00012844671,"teacher_disagreement_score":0.76994956,"about_ca_system_score_codex":0.0012744488,"about_ca_system_score_gemma":0.0032803048,"threshold_uncertainty_score":0.78298026},"labels":[],"label_agreement":null},{"id":"W4405234351","doi":"10.1002/jha2.1061","title":"Red blood cell transfusion and the use of intravenous iron in iron‐deficient patients presenting to the emergency department","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; George & Fay Yee Centre for Healthcare Innovation; Western University; University of Manitoba","funders":"","keywords":"Medicine; Anemia; Hemoglobin; Mean corpuscular volume; Ferritin; Emergency department; Transferrin saturation; Iron deficiency; Blood transfusion; Iron-deficiency anemia; Serum iron; Internal medicine; Pediatrics; Gastroenterology","score_opus":0.016812625593853162,"score_gpt":0.23488067899673593,"score_spread":0.21806805340288277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405234351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909345,0.0006997267,0.00014361346,0.005221193,0.0003579631,0.0017627025,0.00000894401,0.000027559348,0.00084378355],"genre_scores_gemma":[0.9972086,0.0014839511,0.00014386665,0.00022194363,0.000035128174,0.00006728396,0.000010774977,0.00001630016,0.0008121422],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988585,0.00007841501,0.00032397397,0.0002474799,0.0002989946,0.00019262744],"domain_scores_gemma":[0.99957335,0.000051172727,0.000027689035,0.0002621646,0.00002598182,0.00005964208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027646983,0.00011744368,0.00017419475,0.00009030701,0.00006835562,0.0000198631,0.00007987904,0.000033691485,0.00009658752],"category_scores_gemma":[0.000017839562,0.000063527405,0.00007158006,0.0002607406,0.00003834512,0.000035038884,0.00005397615,0.0001429767,0.000008444596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005461933,0.02109899,0.1453904,0.01038979,0.0010583877,0.00076075614,0.34399652,0.005433494,0.037517652,0.009069282,0.061382424,0.35844037],"study_design_scores_gemma":[0.027724141,0.002623384,0.5063353,0.0012244639,0.0033428003,0.00003555125,0.0038893279,0.008961196,0.026368838,0.00021371628,0.4183999,0.0008813328],"about_ca_topic_score_codex":0.0002453977,"about_ca_topic_score_gemma":0.0003101029,"teacher_disagreement_score":0.36094493,"about_ca_system_score_codex":0.000015498857,"about_ca_system_score_gemma":0.000012239397,"threshold_uncertainty_score":0.25905725},"labels":[],"label_agreement":null},{"id":"W4405319926","doi":"10.1002/jha2.1062","title":"Characteristics of relapsed/refractory diffuse large B‐cell lymphoma patients with durable responses to maveropepimut‐S, pembrolizumab, and cyclophosphamide: Long‐term follow‐up from the SPiReL trial","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Hospital; Baker Hughes (Canada); McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Merck Canada; McGill University Health Centre; Ottawa Hospital Research Institute; London Health Sciences Centre; McGill University","keywords":"Pembrolizumab; Medicine; Regimen; Cyclophosphamide; Internal medicine; Oncology; Immunotherapy; Clinical trial; ELISPOT; Lymphoma; Chemotherapy; Immune system; Immunology; T cell; Cancer","score_opus":0.01066533123460231,"score_gpt":0.24273796992625502,"score_spread":0.2320726386916527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405319926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937845,0.0029067204,0.000030711548,0.00036341642,0.0012351808,0.00095605396,0.00048746046,0.0000654454,0.00017054167],"genre_scores_gemma":[0.99380547,0.00075443415,0.000046425055,0.0006516832,0.00025196595,0.000038853555,0.00012762313,0.000060962477,0.004262614],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998354,0.000091760296,0.00043531085,0.00039801333,0.00040726436,0.0003136488],"domain_scores_gemma":[0.9987822,0.00033960812,0.00013348574,0.00051980035,0.00008433301,0.00014058177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024006718,0.00026246518,0.00043187072,0.00008687591,0.000118661934,0.000073801515,0.00015735603,0.00011973914,0.0001709501],"category_scores_gemma":[0.00010316093,0.00016197437,0.00012907908,0.00025223652,0.00012197922,0.000111851696,0.000077723584,0.00015794356,0.00003064209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54465944,0.0024927221,0.38772768,0.00029701958,0.00062172266,0.00030971604,0.0038853805,3.9735397e-8,0.0038019267,0.000019386585,0.0072211255,0.048963875],"study_design_scores_gemma":[0.10772568,0.0019143169,0.86210495,0.0005589325,0.00023472784,0.000008007936,0.00007234635,0.0000051033853,0.0013435024,0.0000053269146,0.025814962,0.00021211412],"about_ca_topic_score_codex":0.0002882567,"about_ca_topic_score_gemma":0.00006574321,"teacher_disagreement_score":0.4743773,"about_ca_system_score_codex":0.0001301904,"about_ca_system_score_gemma":0.00022571385,"threshold_uncertainty_score":0.6605123},"labels":[],"label_agreement":null},{"id":"W4405664260","doi":"10.1002/jha2.1063","title":"Factors related to mean corpuscular volume in <i>HFE</i> p.C282Y homozygotes","year":2024,"lang":"en","type":"article","venue":"eJHaem","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Human Genome Research Institute; University of California, Irvine; Wake Forest University; London Health Sciences Centre; National Heart, Lung, and Blood Institute; University of Minnesota; Kaiser Permanente","keywords":"Mean corpuscular volume; Volume (thermodynamics); Medicine; Internal medicine; Physics; Hematocrit","score_opus":0.014455621112465247,"score_gpt":0.26697786868659606,"score_spread":0.25252224757413083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405664260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821386,0.005518635,0.00010379411,0.0017827828,0.0007774928,0.00035035057,0.000011490062,0.0002466485,0.009070203],"genre_scores_gemma":[0.9873714,0.00007857051,0.00018740955,0.00059134065,0.00007188514,0.000012720311,0.000048578593,0.000046203964,0.011591909],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877083,0.000037892,0.00026177714,0.0003454563,0.0002603575,0.0003236852],"domain_scores_gemma":[0.99941975,0.00004065246,0.000016710173,0.00030623155,0.00002693288,0.00018974407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019166953,0.00018379035,0.00030826172,0.00025877997,0.000035029017,0.000035544996,0.000095517695,0.000115491224,0.0006910675],"category_scores_gemma":[0.00012031086,0.00014674956,0.0001272681,0.0006724786,0.000043888664,0.00009312583,0.00004488099,0.00027265452,0.0010755223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003683386,0.0010194937,0.56185603,0.0018541117,0.0003422817,0.0034484607,0.066827394,0.00041401884,0.025791498,0.021658786,0.211652,0.10476755],"study_design_scores_gemma":[0.0025417993,0.00038180532,0.36250055,0.0005622613,0.0003074035,0.000063794374,0.0038792845,0.0006756064,0.00508908,0.001755447,0.621438,0.00080497545],"about_ca_topic_score_codex":0.00021609211,"about_ca_topic_score_gemma":0.00007273274,"teacher_disagreement_score":0.409786,"about_ca_system_score_codex":0.00004509184,"about_ca_system_score_gemma":0.00007756039,"threshold_uncertainty_score":0.9997023},"labels":[],"label_agreement":null},{"id":"W4406151258","doi":"10.1002/jha2.1005","title":"The association of donor and recipient sex on sepsis rates and hemoglobin increment among critically ill patients receiving red cell transfusions in a retrospective study","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University; University of Alberta","funders":"Canadian Blood Services","keywords":"Sepsis; Medicine; Critically ill; Blood transfusion; Hemoglobin; Retrospective cohort study; Red blood cell; Red Blood Cell Transfusion; Intensive care unit; Multivariate analysis; Internal medicine","score_opus":0.0059603634996624084,"score_gpt":0.2498557497832873,"score_spread":0.2438953862836249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406151258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541147,0.000045040022,0.000016413827,0.0052887355,0.00010662366,0.0014551681,0.0000048144016,0.000016254155,0.007655465],"genre_scores_gemma":[0.99761117,0.00029450984,0.00006881926,0.00064813555,0.000007877878,0.00006391552,0.000002788686,0.0000074596246,0.0012953451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998846,0.00014315656,0.00031128476,0.00026252458,0.00027229512,0.0001647501],"domain_scores_gemma":[0.9992913,0.00018233633,0.000055401353,0.00016229512,0.00025613452,0.000052529413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064335094,0.00011058616,0.00024670508,0.00012196513,0.00013269135,0.0000216092,0.000044961744,0.000052660263,0.000011619574],"category_scores_gemma":[0.0004298326,0.000082202976,0.000033280634,0.00025515808,0.000039545528,0.000033294837,0.000048474703,0.00017392806,4.9174565e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018061898,0.0011157313,0.98820174,0.00005060096,0.00008862321,0.0000035043397,0.0029692543,8.808128e-7,0.00041368202,0.00013366404,0.00081099354,0.0060306946],"study_design_scores_gemma":[0.0044122646,0.00060573115,0.98880905,0.00018864886,0.00014319464,7.3363886e-8,0.004044899,0.000049753362,0.0011668395,0.00008467179,0.00042805076,0.00006683585],"about_ca_topic_score_codex":0.00027194526,"about_ca_topic_score_gemma":0.0018146313,"teacher_disagreement_score":0.012199664,"about_ca_system_score_codex":0.00018631892,"about_ca_system_score_gemma":0.00001931834,"threshold_uncertainty_score":0.33521402},"labels":[],"label_agreement":null},{"id":"W4407414901","doi":"10.1002/jha2.70000","title":"Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta‐Analysis of Cardiovascular Safety","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Ruxolitinib; Subgroup analysis; Meta-analysis; Internal medicine; Myelofibrosis; Adverse effect; Population; Incidence (geometry); Surgery","score_opus":0.027578270535772765,"score_gpt":0.28464209403928714,"score_spread":0.25706382350351437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407414901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354287,0.047247123,0.0011677673,0.0017881548,0.00012488154,0.0027532831,0.00036329252,0.00007380082,0.011053036],"genre_scores_gemma":[0.9951317,0.0011768945,0.0021400894,0.00008073187,0.00004017575,0.00042844977,0.00012138862,0.000021243246,0.00085933186],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99789035,0.00013658304,0.00063939183,0.0005447476,0.0005165659,0.0002723516],"domain_scores_gemma":[0.99816036,0.0002750733,0.00020063494,0.0008135947,0.00041312093,0.00013722085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001624681,0.00040992917,0.002903082,0.0005913178,0.00008476298,0.000011282025,0.00007348067,0.000110398425,0.00020377756],"category_scores_gemma":[0.00003981499,0.0002480154,0.0022373914,0.0015851259,0.00017103524,0.000060985618,0.000025387837,0.0000832643,0.000005924587],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015331671,0.0025674247,0.05313752,0.00017594876,0.9275243,0.00028125648,0.0023278976,0.003119761,0.00019813055,0.0032068111,0.00008342778,0.0058443383],"study_design_scores_gemma":[0.0074092993,0.003865839,0.036641914,0.00011389734,0.7408294,0.000024314075,0.00066990213,0.000495113,0.1991568,0.000035768157,0.0104486,0.0003091079],"about_ca_topic_score_codex":0.0007423981,"about_ca_topic_score_gemma":0.00030516458,"teacher_disagreement_score":0.19895868,"about_ca_system_score_codex":0.00021472987,"about_ca_system_score_gemma":0.0003156988,"threshold_uncertainty_score":0.9999972},"labels":[],"label_agreement":null},{"id":"W4408927697","doi":"10.1002/jha2.70026","title":"Leaky Artemis Deficiency and EBV‐Related Lymphoproliferative Disease: A Novel Case and Review of the Literature","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Lymphoproliferative disease; Lymphoproliferative disorders; Medicine; Disease; Immunology; Pathology; Lymphoma","score_opus":0.0043093851811540455,"score_gpt":0.2245747101784956,"score_spread":0.22026532499734156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408927697","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32547218,0.6715902,0.000018551058,0.0010992972,0.00022247808,0.00027857127,0.000048435297,0.00001705309,0.0012532042],"genre_scores_gemma":[0.9841791,0.010917508,0.0000051232764,0.0008044553,7.273375e-7,0.000018863746,0.000022638615,0.0000056370855,0.0040459624],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913913,0.00011774027,0.00028886794,0.0002416461,0.000026742773,0.00018587483],"domain_scores_gemma":[0.9994411,0.00008368002,0.00010312521,0.00029356795,0.000071738126,0.0000068050895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021048689,0.00015520604,0.00025358505,0.000053096268,0.0003327899,0.000014799926,0.00013116447,0.00011482483,0.000043414264],"category_scores_gemma":[0.00020739863,0.00010207633,0.00007849539,0.0003815041,0.0004293552,0.000065334294,0.00013113853,0.00021809786,0.0000052130417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011243509,0.003524163,0.019742014,0.039726444,0.0019865267,0.00056348904,0.053201884,0.000026765518,0.41200602,0.18712181,0.01280819,0.26816836],"study_design_scores_gemma":[0.031145485,0.00085730164,0.2857514,0.14838186,0.0039191386,0.020907458,0.015867217,0.00034505344,0.056657284,0.011001807,0.42100558,0.004160418],"about_ca_topic_score_codex":0.000031070114,"about_ca_topic_score_gemma":0.000001582938,"teacher_disagreement_score":0.6606727,"about_ca_system_score_codex":0.000013174114,"about_ca_system_score_gemma":0.00012157174,"threshold_uncertainty_score":0.4162552},"labels":[],"label_agreement":null},{"id":"W4409042941","doi":"10.1002/jha2.1109","title":"Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Dalhousie University; University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Immunophenotyping; Phenotype; CD5; Flow cytometry; Eosinophilia; CD8; Hypereosinophilic syndrome; Immunology; Medicine; Pathology; Internal medicine; Biology; Antigen; Genetics; Gene","score_opus":0.009513727154250784,"score_gpt":0.22856217528983092,"score_spread":0.21904844813558014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409042941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98745227,0.0010652294,0.000006787652,0.003665862,0.00054374896,0.0003213831,0.000069274094,0.00004133945,0.006834114],"genre_scores_gemma":[0.9945197,0.000070360235,0.0001623579,0.0026057013,0.000030896925,0.000033191438,0.00007085018,0.00002297719,0.0024839393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985208,0.000057515696,0.00040277024,0.00040045063,0.00021665971,0.00040181124],"domain_scores_gemma":[0.9992285,0.00006215612,0.000043853863,0.0004886988,0.000034470042,0.00014232495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007708354,0.00023428131,0.00049250317,0.00016278928,0.00007739543,0.000022919552,0.00012497541,0.00009284564,0.00038861213],"category_scores_gemma":[0.000051405183,0.00020627868,0.000071108145,0.00031899917,0.0000736355,0.000111597874,0.000090613314,0.0002074409,0.00002363545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005295793,0.00059613126,0.49751672,0.00047267677,0.00046017484,0.46310592,0.0017163755,0.000035277746,0.0004243141,0.00083795254,0.019741766,0.014563111],"study_design_scores_gemma":[0.014948353,0.0003822943,0.78430915,0.0021478627,0.0003891601,0.15920891,0.0075898943,0.0015432141,0.00040824444,0.002724269,0.025256678,0.0010919897],"about_ca_topic_score_codex":0.85612524,"about_ca_topic_score_gemma":0.85919195,"teacher_disagreement_score":0.30389702,"about_ca_system_score_codex":0.0012227946,"about_ca_system_score_gemma":0.0024619324,"threshold_uncertainty_score":0.84118},"labels":[],"label_agreement":null},{"id":"W4410266714","doi":"10.1002/jha2.70045","title":"A Single‐Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Abnormality; Internal medicine; Multiple myeloma; Cohort; Oncology; Cancer; Gastroenterology","score_opus":0.03853036811070795,"score_gpt":0.31961650582521733,"score_spread":0.2810861377145094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410266714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278283,0.000057317233,0.00010887383,0.0003343547,0.00012490914,0.0037248305,0.00019979318,0.00008066601,0.0025864255],"genre_scores_gemma":[0.98979354,0.0000037130517,0.00076637394,0.00018884477,0.00007522358,0.00069372926,0.00036508185,0.000030277342,0.008083216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857503,0.000049123355,0.00023477431,0.00038701316,0.0003300638,0.0004239992],"domain_scores_gemma":[0.999009,0.00019417284,0.000049833572,0.00041614549,0.0001723605,0.00015846461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006152761,0.0002649773,0.0003893334,0.0001835286,0.00015067577,0.000033473265,0.00007599924,0.00004829893,0.00004707344],"category_scores_gemma":[0.000103541024,0.00016585723,0.00010916889,0.00012860482,0.0000481302,0.000062464715,0.000034227673,0.00007537644,0.000037882746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007679021,0.014218936,0.9467573,0.000047970723,0.0008935191,0.00007123094,0.00078092807,0.00000214412,0.000033125267,0.000022680015,0.0008283085,0.028664825],"study_design_scores_gemma":[0.054185383,0.01622125,0.9146286,0.0001731324,0.0001899595,0.0000025936733,0.00089394447,0.000128252,0.0019749636,0.0000120000905,0.01143027,0.00015963157],"about_ca_topic_score_codex":0.00016117557,"about_ca_topic_score_gemma":0.00035107273,"teacher_disagreement_score":0.046506364,"about_ca_system_score_codex":0.00039170505,"about_ca_system_score_gemma":0.000084438136,"threshold_uncertainty_score":0.6763461},"labels":[],"label_agreement":null},{"id":"W4410771493","doi":"10.1002/jha2.70054","title":"Sporadic Porphyria Cutanea Tarda, Cutaneous Sarcoidosis, and Compound Heterozygosity of HFE Mutations Cys282Tyr and His63Asp—A Case Report","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Porphyria cutanea tarda; Uroporphyrinogen III decarboxylase; Sarcoidosis; Hemochromatosis; Compound heterozygosity; Loss of heterozygosity; Porphyria; Hereditary hemochromatosis; Medicine; Steatosis; Genetics; Biology; Internal medicine; Mutation; Heme; Gene; Allele; Biochemistry; Enzyme","score_opus":0.005092419265139535,"score_gpt":0.24536021075435202,"score_spread":0.24026779148921248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410771493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919597,0.005042062,0.000451432,0.00018305748,0.00016685307,0.00019779915,0.000080162914,0.000015605396,0.0019033357],"genre_scores_gemma":[0.9976232,0.000328563,0.0010030553,0.0002162595,0.00004818488,0.000008878629,0.00016903883,0.000012961019,0.00058988127],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99894375,0.00005287277,0.00031855502,0.00039358172,0.00009736616,0.00019387688],"domain_scores_gemma":[0.99930185,0.000024758065,0.00013431856,0.00036911573,0.00007035932,0.000099617944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014093322,0.00017525564,0.00026052332,0.000079493264,0.00013847866,0.000024430212,0.00008748286,0.00012391855,0.0000122749525],"category_scores_gemma":[0.00008953644,0.00017837752,0.000066704364,0.00011519317,0.00028595637,0.0000068970544,0.00012513959,0.000082806655,0.000001327524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085993955,0.00095697766,0.20654091,0.00077661686,0.0010494946,0.056437872,0.0012223695,0.00015333193,0.69123584,0.0038085629,0.01680688,0.020151215],"study_design_scores_gemma":[0.008926152,0.0012627749,0.10858606,0.00023325338,0.0014822804,0.38371778,0.003396701,0.0006497845,0.25924495,0.008792976,0.22092949,0.0027777797],"about_ca_topic_score_codex":0.00040391425,"about_ca_topic_score_gemma":0.00018822224,"teacher_disagreement_score":0.43199086,"about_ca_system_score_codex":0.0000071354575,"about_ca_system_score_gemma":0.00007997993,"threshold_uncertainty_score":0.72740245},"labels":[],"label_agreement":null},{"id":"W4410811746","doi":"10.1002/jha2.70061","title":"Efficacy of Total‐Body Irradiation‐based Intensified Myeloablative Regimens for Acute Leukemia—An International Collaborative Study","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; MorphoSys; National Cancer Institute; Servier; Teijin Pharma; Otsuka Pharmaceutical; Meiji Seika Pharma; JCR Pharmaceuticals; Health Resources and Services Administration; Syndax Pharmaceuticals; Astellas Pharma; Eisai; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Omeros Corporation; Vertex Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; Regeneron Pharmaceuticals; Medical College of Wisconsin; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; Chugai Pharmaceutical; National Marrow Donor Program; HistoGenetics; Fuji Pharma; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Nippon Shinyaku; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Novartis Pharma; AbbVie; Kyowa Hakko Kirin; Sanofi","keywords":"Total body irradiation; Medicine; Internal medicine; Etoposide; Cytarabine; Hazard ratio; Hematopoietic stem cell transplantation; Cohort; Myeloid leukemia; Cyclophosphamide; Transplantation; Acute leukemia; Leukemia; Gastroenterology; Oncology; Surgery; Chemotherapy; Confidence interval","score_opus":0.020730385808519693,"score_gpt":0.35224623053895826,"score_spread":0.33151584473043855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410811746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979237,0.000017501094,0.0106161805,0.0009868543,0.00054444984,0.0027060548,0.00014826069,0.00007424826,0.005669447],"genre_scores_gemma":[0.99333674,0.000004850946,0.003917785,0.0002579358,0.000070394824,0.00016145688,0.0003806555,0.000019795572,0.0018503839],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99868244,0.000082919796,0.00045316515,0.0003326762,0.0002880935,0.00016070523],"domain_scores_gemma":[0.9981469,0.0004787352,0.00017267672,0.00032436845,0.0008020223,0.00007529252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026028225,0.00016653784,0.00039999912,0.0002743297,0.00006483719,0.000017230646,0.0001133561,0.00008506875,0.00006497478],"category_scores_gemma":[0.00024938115,0.00015552915,0.00008556336,0.0004661315,0.0000698331,0.000119458025,0.000015474334,0.00011371451,0.000009314399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09325904,0.01779723,0.18685938,0.0020821404,0.028315434,0.0006276779,0.20375264,0.0067169443,0.35696957,0.062389225,0.022202792,0.019027939],"study_design_scores_gemma":[0.043864932,0.003940027,0.7406503,0.00080331694,0.0028954358,0.000024989244,0.01666373,0.028686896,0.160366,0.00032345112,0.0012528261,0.00052812713],"about_ca_topic_score_codex":0.000028244827,"about_ca_topic_score_gemma":0.000014571761,"teacher_disagreement_score":0.55379087,"about_ca_system_score_codex":0.000261294,"about_ca_system_score_gemma":0.00056512794,"threshold_uncertainty_score":0.6342295},"labels":[],"label_agreement":null},{"id":"W4410929433","doi":"10.1002/jha2.70071","title":"A Comparative Study of the Outcomes of Surgically Versus Non‐Surgically Treated Spinal Disease in Patients With Multiple Myeloma: Northern Ireland's Experience","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Medicine; Cohort; Multiple myeloma; Retrospective cohort study; Surgery; Cohort study; Malignancy; Bone marrow; Back pain; Internal medicine; Pathology","score_opus":0.025385542065117252,"score_gpt":0.3274377467584394,"score_spread":0.30205220469332217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410929433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976503,0.00003125927,0.000003233858,0.00006752476,0.000045945806,0.00167302,0.000027969496,0.000012383749,0.00048834324],"genre_scores_gemma":[0.9995641,0.0000017900819,0.000031089512,0.000007895132,0.000004179569,0.000117752046,0.000019356636,0.000008564564,0.0002452414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983861,0.00012339736,0.00036895837,0.0002907959,0.00058156,0.00024918202],"domain_scores_gemma":[0.9988303,0.00021019945,0.00012349569,0.00044227467,0.00024762226,0.00014606556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069094436,0.00019382269,0.00058288424,0.00012185253,0.000064226566,0.000007056243,0.00018443937,0.000035791956,0.000027673],"category_scores_gemma":[0.00016036378,0.000101425234,0.00009687759,0.0005193018,0.00018464462,0.000050595732,0.00010360409,0.00014180804,0.000003660208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027444722,0.0053829937,0.9640289,0.000028807097,0.00040251896,0.00009680526,0.0018475802,0.000041879568,0.000014787626,0.0000043291184,0.000003827867,0.00070284214],"study_design_scores_gemma":[0.037215248,0.0021098007,0.95895267,0.00014519694,0.0001019705,1.8866278e-7,0.0009734012,0.00023239007,0.00017682862,0.000001162839,0.000011749862,0.000079374164],"about_ca_topic_score_codex":0.0010186451,"about_ca_topic_score_gemma":0.0023679892,"teacher_disagreement_score":0.009770527,"about_ca_system_score_codex":0.000092595576,"about_ca_system_score_gemma":0.00016127342,"threshold_uncertainty_score":0.41360012},"labels":[],"label_agreement":null},{"id":"W4411085883","doi":"10.1002/jha2.70072","title":"Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; Gilead Sciences","keywords":"Daratumumab; Medicine; Pomalidomide; Internal medicine; Dexamethasone; Clinical endpoint; Multiple myeloma; Refractory (planetary science); Neutropenia; Adverse effect; Oncology; Phases of clinical research; Clinical trial; Lenalidomide; Toxicity","score_opus":0.03366329470104022,"score_gpt":0.33531640225832565,"score_spread":0.3016531075572854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411085883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964804,0.000052666477,0.000022742859,0.00006731442,0.00003982752,0.0017246044,0.000116158975,0.00002125481,0.0014750126],"genre_scores_gemma":[0.9983552,0.0000043774107,0.0005832279,0.000014817924,0.000006052886,0.000078563746,0.00016468712,0.000015004505,0.00077807176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982998,0.00011346203,0.00053218566,0.00030961703,0.00047931113,0.00026565773],"domain_scores_gemma":[0.99864733,0.00024220409,0.000168405,0.00046438698,0.00037429528,0.00010339941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017964414,0.00016867844,0.000446063,0.00048822956,0.00005165511,0.0000056981817,0.00012338629,0.00006346606,0.000021724556],"category_scores_gemma":[0.00058984454,0.00012966356,0.000056226927,0.000585277,0.00009860447,0.00009431852,0.000070695474,0.00022138613,0.000006287177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016791813,0.07841675,0.8858926,0.000118587624,0.0003071936,0.000116367504,0.0014556447,0.000008138668,0.00025289593,0.000022382164,0.00021011636,0.016407466],"study_design_scores_gemma":[0.1879635,0.0070953807,0.80219424,0.00021769079,0.00007366581,6.79344e-7,0.00062484556,0.00060286775,0.0010549519,0.000008523335,0.00008967487,0.00007398545],"about_ca_topic_score_codex":0.0005432422,"about_ca_topic_score_gemma":0.00056444283,"teacher_disagreement_score":0.1711717,"about_ca_system_score_codex":0.00012480271,"about_ca_system_score_gemma":0.00017504537,"threshold_uncertainty_score":0.5287527},"labels":[],"label_agreement":null},{"id":"W4411963051","doi":"10.1002/jha2.70092","title":"Serum Ferritin in Women With <i>HFE</i> p.C282Y Homozygosity: Positive Associations With Age, Live Births, Menopause, and Transferrin Saturation","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of California, Irvine; University of Illinois at Urbana-Champaign; National Human Genome Research Institute; University of Alabama; National Heart, Lung, and Blood Institute; University of Minnesota; London Health Sciences Centre; Wake Forest University; National Cancer Institute; Kaiser Permanente; University of Alabama at Birmingham; U.S. Department of Veterans Affairs","keywords":"Medicine; Phlebotomy; Transferrin saturation; Ferritin; Menopause; Pregnancy; Serum iron; Gynecology; Obstetrics; Live birth; Anemia; Physiology; Internal medicine; Serum ferritin; Biology","score_opus":0.005075507770104428,"score_gpt":0.22987548131091948,"score_spread":0.22479997354081505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411963051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843714,0.0005728544,0.00024809048,0.0031708537,0.000040823837,0.00065103854,0.00007281859,0.00006360576,0.010808519],"genre_scores_gemma":[0.9952094,0.00017711581,0.0005256797,0.0018865546,0.0000331188,0.00007401937,0.000062671264,0.000020004863,0.0020114614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989072,0.00007856822,0.000190099,0.00029791254,0.00021110375,0.0003150917],"domain_scores_gemma":[0.99955624,0.00006430495,0.000042397805,0.000161533,0.00007653151,0.000098993114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016371043,0.00018454707,0.0003491733,0.00019258159,0.00012253832,0.00004585583,0.00005078862,0.000094556264,0.00003213942],"category_scores_gemma":[0.000029541969,0.0001463172,0.000016185042,0.00048678243,0.00009989548,0.00016222768,0.000017371322,0.00025829914,0.00000646102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015115802,0.0034932408,0.6985295,0.0012026128,0.0012322358,0.002159613,0.1393986,0.00019909062,0.015012597,0.03008193,0.0060947062,0.08748009],"study_design_scores_gemma":[0.00588788,0.0005966273,0.984572,0.00025045994,0.00016386039,0.000021298722,0.005910858,0.00001267647,0.0011169561,0.0003263824,0.0009162028,0.00022478706],"about_ca_topic_score_codex":0.000414112,"about_ca_topic_score_gemma":0.0031113634,"teacher_disagreement_score":0.28604254,"about_ca_system_score_codex":0.00012694628,"about_ca_system_score_gemma":0.0001776388,"threshold_uncertainty_score":0.5966642},"labels":[],"label_agreement":null},{"id":"W4412163515","doi":"10.1002/jha2.70102","title":"Acute Lung Injury in a Healthy Peripheral Blood Stem Cell Donor Following Granulocyte‐colony Stimulating Factor Administration: A Case Report","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Granulocyte colony-stimulating factor; Granulocyte; Medicine; Peripheral blood; Stem cell; Lung; Administration (probate law); Peripheral Blood Stem Cells; Peripheral; Immunology; Internal medicine; Transplantation; Biology; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.019918006260277104,"score_gpt":0.3308065843684804,"score_spread":0.3108885781082033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947025,0.0002728499,0.00054805324,0.00044634903,0.0007275524,0.001053462,0.000016444988,0.00012345384,0.0021093162],"genre_scores_gemma":[0.99249166,0.000004618644,0.0013509745,0.0009584908,0.00014567586,0.00010671195,0.00003434273,0.00003070656,0.004876834],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790764,0.000068556,0.00078450114,0.00051851565,0.00027808652,0.00044269476],"domain_scores_gemma":[0.9990198,0.000048994254,0.00017597995,0.00046093605,0.00006528138,0.00022901283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034771275,0.00026216137,0.00054349715,0.00021334717,0.00018081622,0.000050901133,0.00008397761,0.00018773953,0.00011499719],"category_scores_gemma":[0.000032169923,0.00025188763,0.00021280999,0.00041237153,0.000021290289,0.00016161792,0.000054656484,0.00037212472,0.000006148853],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025953287,0.00082853605,0.27515888,0.00078487926,0.0004675681,0.6722919,0.0030917837,0.000012566622,0.034211695,0.00018244403,0.00076571613,0.009608719],"study_design_scores_gemma":[0.09301848,0.032542072,0.06618454,0.004574392,0.008178896,0.14507549,0.017299654,0.014290844,0.53714216,0.00035426609,0.07521297,0.0061262148],"about_ca_topic_score_codex":0.00007358245,"about_ca_topic_score_gemma":0.00013867454,"teacher_disagreement_score":0.52721643,"about_ca_system_score_codex":0.00019015835,"about_ca_system_score_gemma":0.0009247086,"threshold_uncertainty_score":0.9999933},"labels":[],"label_agreement":null},{"id":"W4412366392","doi":"10.1002/jha2.70077","title":"Morphologic and Electrophoretic Features of Hemoglobin Bart's Hydrops Fetalis","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hydrops fetalis; Hemoglobin; Medicine; Fetus; Pregnancy; Biology; Internal medicine; Genetics","score_opus":0.0065069964621215825,"score_gpt":0.2535752973372797,"score_spread":0.2470683008751581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412366392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97049224,0.002402662,0.00007031326,0.0014018529,0.00020560261,0.00015610323,0.0000049883906,0.000041996358,0.02522423],"genre_scores_gemma":[0.98871106,0.00026668026,0.0004082257,0.0017631477,0.00005142361,0.0000066496173,0.000022732318,0.0000061411915,0.00876397],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994441,0.00003723449,0.00013297699,0.00018001065,0.00006681818,0.00013885483],"domain_scores_gemma":[0.9996478,0.00004422709,0.000035388366,0.00018426945,0.000042374853,0.000045967416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005937473,0.00009267232,0.00025797848,0.000088801855,0.000035327157,0.000003488668,0.000038220373,0.00009518031,0.0002526535],"category_scores_gemma":[0.00007106765,0.000071580325,0.000055486533,0.00018712213,0.00013842204,0.000014317681,0.000032768225,0.00014657821,0.000015178261],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009046107,0.00019605902,0.0074056983,0.00031514242,0.00015197098,0.00014252946,0.00025732405,0.0000046130795,0.89609796,0.011380787,0.06627562,0.016867679],"study_design_scores_gemma":[0.00693687,0.003753756,0.4908357,0.00036751112,0.000546338,0.0011203677,0.00047508298,0.000419538,0.41203564,0.011528148,0.07147727,0.00050377584],"about_ca_topic_score_codex":0.000029063727,"about_ca_topic_score_gemma":0.0000049485293,"teacher_disagreement_score":0.4840623,"about_ca_system_score_codex":0.000018741062,"about_ca_system_score_gemma":0.000044344124,"threshold_uncertainty_score":0.2918961},"labels":[],"label_agreement":null},{"id":"W4414449058","doi":"10.1002/jha2.70145","title":"Real‐World Treatment Patterns and Clinical Outcomes Among Patients With Triple‐Class–Exposed and BCMA‐Exposed Multiple Myeloma Within the United States","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Johnson and Johnson","keywords":"Multiple myeloma; Clinical trial; MEDLINE; Disease; Incidence (geometry)","score_opus":0.035874759921380936,"score_gpt":0.3299574661307874,"score_spread":0.29408270620940646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414449058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962967,0.000037513564,0.000020506264,0.0009975382,0.00012671496,0.001939813,0.00012841566,0.000097023585,0.0003557543],"genre_scores_gemma":[0.9940276,0.00027011105,0.0003305052,0.00038317352,0.000034743185,0.00012427646,0.00060041796,0.000037493603,0.0041916873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773526,0.00027066638,0.00056371436,0.00056484056,0.00041134175,0.0004541571],"domain_scores_gemma":[0.99763936,0.0010904275,0.00016845265,0.00056852546,0.0001627369,0.0003705189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027105803,0.000387251,0.0006532221,0.00032160923,0.00028382955,0.000088987705,0.00011716782,0.000103070124,0.00003024592],"category_scores_gemma":[0.00026287115,0.00019935786,0.00011363034,0.00042171814,0.00038048756,0.000095945885,0.00011128586,0.00028357515,0.0000074601435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017394089,0.0008239284,0.98507607,0.000047412694,0.0011730111,0.00011106758,0.00054785324,0.0000027523768,0.0000074001996,0.000039221388,0.00019865234,0.010233234],"study_design_scores_gemma":[0.02388203,0.0016786833,0.9702647,0.00016392802,0.00033279444,0.0000022263257,0.0005217855,0.0019769543,0.00035107136,0.000026370657,0.0006225987,0.00017688476],"about_ca_topic_score_codex":0.0062362347,"about_ca_topic_score_gemma":0.0138572315,"teacher_disagreement_score":0.02214262,"about_ca_system_score_codex":0.00016457644,"about_ca_system_score_gemma":0.0001239386,"threshold_uncertainty_score":0.94273627},"labels":[],"label_agreement":null},{"id":"W4415279750","doi":"10.1002/jha2.70137","title":"Uncommon Evolution From Acute Myeloid Leukaemia to <i>JAK2</i> ‐Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From <i>TET2</i> / <i>SRSF2</i> ‐Mutated Haematopoietic Progenitors","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada; University Health Network","funders":"","keywords":"Haematopoiesis; Persistence (discontinuity); Divergence (linguistics); Myeloid; Myeloid leukaemia; Progenitor cell; Mutation","score_opus":0.022306823247814994,"score_gpt":0.2984109368507909,"score_spread":0.27610411360297593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415279750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697287,0.0038334355,0.0022886528,0.0033689667,0.00048130593,0.0018674652,0.00038000982,0.00022385379,0.00058343075],"genre_scores_gemma":[0.9898787,0.0005066428,0.0067857215,0.0011037028,0.00017132003,0.00019942083,0.00022057688,0.000061860956,0.0010720392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527425,0.00026724517,0.0010322378,0.0013648787,0.0011948019,0.0008665966],"domain_scores_gemma":[0.99632096,0.0009021609,0.00029791123,0.0009913628,0.0008793014,0.00060830434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048175984,0.00064205646,0.0012151253,0.00042968028,0.00034937813,0.00008168504,0.0006886514,0.00038027612,0.00013219875],"category_scores_gemma":[0.00079487363,0.0005947176,0.00024267388,0.0020238946,0.0006400783,0.00047328093,0.00079082494,0.00093258475,0.00015165363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007442358,0.00042003946,0.3013424,0.00056514586,0.0020018045,0.00096818333,0.007699813,0.00022987828,0.6591694,0.0003206761,0.0145508675,0.0052894424],"study_design_scores_gemma":[0.0065988153,0.0015949972,0.12812077,0.005474101,0.0020176203,0.00025878072,0.003862332,0.0065834555,0.84038126,0.0022780786,0.0014834498,0.0013463178],"about_ca_topic_score_codex":0.0029449565,"about_ca_topic_score_gemma":0.0003248442,"teacher_disagreement_score":0.1812119,"about_ca_system_score_codex":0.0011012851,"about_ca_system_score_gemma":0.0016298399,"threshold_uncertainty_score":0.9996504},"labels":[],"label_agreement":null},{"id":"W4415279909","doi":"10.1002/jha2.70163","title":"Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"Pfizer Foundation; Astellas Pharma; BD; Pfizer","keywords":"Standardization; Myeloid leukemia; Multicenter study; Clinical trial; Disease; Residual; Quality (philosophy); Standard of care","score_opus":0.013543321969545908,"score_gpt":0.31522875968341585,"score_spread":0.30168543771386996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415279909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905782,0.0005456398,0.00405173,0.0011335633,0.00012272659,0.0016693465,0.00019244583,0.000068541085,0.0016378075],"genre_scores_gemma":[0.99358314,0.000094511415,0.0008181431,0.00020671583,0.00004358023,0.000082889186,0.00012065113,0.00003144576,0.0050189476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976245,0.0002102153,0.0004924091,0.0004392669,0.00082489033,0.00040871548],"domain_scores_gemma":[0.9986993,0.00012810367,0.00007907435,0.0005861426,0.00030200605,0.00020533687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007926278,0.00020273545,0.0004968481,0.0006024468,0.000067039895,0.000027912418,0.0002201772,0.00009296076,0.00012812954],"category_scores_gemma":[0.0007487192,0.00018109083,0.00007685521,0.0013949018,0.00009756923,0.00014707675,0.00016685773,0.0004028278,0.000023936554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01117108,0.0020078123,0.8471642,0.0005962545,0.0010623704,0.000824745,0.0027395973,0.0012763453,0.03394339,0.000053380616,0.08939555,0.009765252],"study_design_scores_gemma":[0.048725504,0.0015695891,0.8249353,0.0013399423,0.0012904129,0.0000072812477,0.0040656077,0.029191038,0.068930455,0.00013992077,0.01902979,0.00077516126],"about_ca_topic_score_codex":0.00033711677,"about_ca_topic_score_gemma":0.00008224125,"teacher_disagreement_score":0.07036576,"about_ca_system_score_codex":0.0015674164,"about_ca_system_score_gemma":0.0012548066,"threshold_uncertainty_score":0.738467},"labels":[],"label_agreement":null},{"id":"W4415620886","doi":"10.1002/jha2.70164","title":"Secondary Malignancies Following CAR T‐Cell Therapy for B‐Cell Malignancies: A Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Ontario Clinical Oncology Group; McMaster University; Juravinski Cancer Centre; Juravinski Hospital","funders":"Ontario Institute for Cancer Research; Government of Ontario; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Complication; Malignancy; Retrospective cohort study; Clinical trial; Adverse effect; MEDLINE","score_opus":0.01787858321658435,"score_gpt":0.3086770106493665,"score_spread":0.2907984274327821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415620886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92806536,0.006576405,0.0021127774,0.00079842843,0.0004075873,0.0018114398,0.000077469274,0.00017103879,0.059979472],"genre_scores_gemma":[0.8406456,0.00037059092,0.0012223513,0.0011071361,0.00017986343,0.00029106115,0.0000761964,0.000057284637,0.15604989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750584,0.00008720995,0.00043790427,0.00072614104,0.00053431955,0.00070860784],"domain_scores_gemma":[0.9982945,0.00028048843,0.000102244776,0.00083848595,0.00031829203,0.00016602475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068903144,0.00033666848,0.00092240353,0.00071292906,0.00024835314,0.00008103493,0.00029038297,0.00020107922,0.00200154],"category_scores_gemma":[0.00009421095,0.000300348,0.001216402,0.0019452563,0.00011013497,0.00010940221,0.00008594597,0.00037843184,0.000036185862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014106387,0.0008665012,0.10711407,0.00044985913,0.0045956965,0.0002209056,0.0040744417,0.00002358144,0.85113806,0.00052154675,0.020700792,0.008883924],"study_design_scores_gemma":[0.013227726,0.0019287465,0.0673481,0.00021088643,0.0021130415,0.000008900851,0.0038756942,0.0006660828,0.73165745,0.0013048293,0.1768977,0.00076084485],"about_ca_topic_score_codex":0.00015957063,"about_ca_topic_score_gemma":0.00006983911,"teacher_disagreement_score":0.1561969,"about_ca_system_score_codex":0.00043488012,"about_ca_system_score_gemma":0.00056782033,"threshold_uncertainty_score":0.99994487},"labels":[],"label_agreement":null},{"id":"W4416364619","doi":"10.1002/jha2.70179","title":"Paroxysmal Nocturnal Hemoglobinuria in Pregnancy Treated With Pegcetacoplan: Case Report and Pharmacokinetic Analysis","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; London Health Sciences Centre; Western University","funders":"Swedish Orphan Biovitrum","keywords":"Paroxysmal nocturnal hemoglobinuria; Pregnancy; Anemia; Pharmacokinetics; Clinical trial; Hemoglobinuria; Gestation; Hemolytic anemia","score_opus":0.010224497398897402,"score_gpt":0.27562131089323666,"score_spread":0.26539681349433925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416364619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186695,0.005359482,0.00007486765,0.00011136187,0.00013040219,0.00035739288,0.000043875243,0.000055199573,0.0020004855],"genre_scores_gemma":[0.995409,0.000014464479,0.00003580212,0.000038009533,0.000009540937,0.000062698826,0.00013599635,0.0000072819616,0.0042871744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988017,0.000165237,0.00036532115,0.00037137687,0.000031011405,0.00026533916],"domain_scores_gemma":[0.99943596,0.00008413763,0.00011662353,0.0002943334,0.000042017942,0.00002691758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010895791,0.00017902866,0.00037348634,0.0003220593,0.00009790835,0.000019211499,0.00009638556,0.00007191736,0.0007390653],"category_scores_gemma":[0.000023642368,0.00014301052,0.000067617344,0.0006253993,0.00009601199,0.000050167553,0.00006416346,0.00013624186,0.000017284887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002884784,0.00015874657,0.9422242,0.00007343026,0.0018232854,0.04854014,0.00018187313,0.000073904186,0.0034701857,0.000060818107,0.001617782,0.0014871266],"study_design_scores_gemma":[0.0122703975,0.0003086304,0.87801,0.0008154233,0.0057271607,0.07438822,0.00086545723,0.00022891157,0.020324985,0.00006874286,0.006182419,0.0008096799],"about_ca_topic_score_codex":0.0004869741,"about_ca_topic_score_gemma":0.0007746094,"teacher_disagreement_score":0.06421425,"about_ca_system_score_codex":0.00004662522,"about_ca_system_score_gemma":0.000056522134,"threshold_uncertainty_score":0.80922467},"labels":[],"label_agreement":null},{"id":"W4417079158","doi":"10.1002/jha2.70183","title":"Disseminated Histoplasmosis Diagnosed on Peripheral Blood Film","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Biotalent Canada","keywords":"Respiratory distress; Histoplasma; Histoplasmosis; Amphotericin B; Respiratory failure; Sputum; Partial thromboplastin time; Pneumonia; Pleural effusion","score_opus":0.00846651008116672,"score_gpt":0.2749473142055679,"score_spread":0.26648080412440117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417079158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89054185,0.00056062196,0.000015112109,0.0020541828,0.0004299845,0.0001470791,0.0000060141147,0.000106874155,0.1061383],"genre_scores_gemma":[0.950244,0.00010085687,0.00008864714,0.0007389257,0.000054553046,0.000046093985,0.000010325813,0.000007824067,0.048708767],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99948883,0.000013417381,0.00011642153,0.00016189438,0.0000804765,0.00013897706],"domain_scores_gemma":[0.9996177,0.00009899164,0.000017632332,0.00017620006,0.00004868049,0.000040822062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041817402,0.00010012011,0.00018783152,0.00007678238,0.00014102765,0.000009883783,0.00003203239,0.00005031903,0.0003407557],"category_scores_gemma":[0.000159257,0.00007969194,0.00007936329,0.00022187221,0.000043181917,0.000017887094,0.000022463339,0.00013421234,0.00004305504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004266976,0.0027548575,0.29519552,0.00028797745,0.001008906,0.0006205052,0.0022920317,0.0000522448,0.013189204,0.00796684,0.6567958,0.019409444],"study_design_scores_gemma":[0.0041166227,0.001342662,0.6558182,0.0007084463,0.00059234776,0.00003636396,0.0008644195,0.00036768228,0.030160723,0.00013096472,0.30551827,0.00034325742],"about_ca_topic_score_codex":0.00006326398,"about_ca_topic_score_gemma":0.00003396801,"teacher_disagreement_score":0.3606227,"about_ca_system_score_codex":0.00006582508,"about_ca_system_score_gemma":0.000025899235,"threshold_uncertainty_score":0.37310362},"labels":[],"label_agreement":null}]}